HOME     PROGRAM     AUTHOR INDEX     SUBJECT INDEX         


         Invited Talks     


      Keynote Address - The Aftermath from Fetal-Maternal Cell Traffic of Pregnancy
      Sunday, July 24, 2005
      1:30 PM–2:30 PM
      Location: CCQ 2000BC

      KA1. THE AFTERMATH FROM FETAL-MATERNAL CELL TRAFFIC OF PREGNANCY. Nelson, J. Lee1, 1 University of Washington, Seattle, WA
           During pregnancy some cells traffic between the fetus and the mother. Low levels of cells have recently been found to persist in respective hosts many years later. The term microchimerism refers to harboring small numbers of cells (or DNA) by one individual derived from another genetically distinct individual. Chronic graft-versus-host disease occurs as a complication of hematopoietic cell transplantation, is an iatrogenic form of chimerism, and has clinical similarities to some autoimmune diseases. The HLA-relationship of the donor and host is a key determinant of graft-versus-host disease risk. Considering these observations together led to the hypothesis that naturally acquired microchimerism from pregnancy and HLA genes of different cell populations are involved in autoimmune diseases. In addition to cells from a fetus there are other sources of microchimerism so that the hypothesis is also applicable to children, men and women who have never been pregnant. Long-term persistence of maternal microchimerism in her adult progeny has been reported, as has persistence from cell transfer between twins in utero. Microchimerism can result from a blood transfusion, and possibly could occur due to cells from an older sibling passed via the maternal circulation in a subsequent pregnancy. Microchimerism has been investigated in systemic sclerosis (scleroderma), primary biliary cirrhosis, Sjogrens syndrome, polymorphic eruption of pregnancy, myositis, thyroid disease and systemic lupus. Results lend support to a potential role for microchimerism in some diseases, while also indicating microchimerism is often found in healthy individuals. Very recently microchimeric cells that bear tissue specific antigens have been identified, for example cardiac myocytes. It is likely the microchimerism can have both beneficial and detrimental effects on the host. An example of the former would be in tissue repair and of the later, tissue-specific microchimerism could be the target of an "auto-allo" immune response.



      President's Symposium - Immune Cells in Reproduction: A New Frontier
      Monday, July 25, 2005
      4:30 PM–6:30 PM
      Location: CCQ 2000BC

      PS1. IMMUNE REGULATION OF OVARIAN FUNCTION IN EARLY PREGNANCY. Erlebacher, Adrian1, 2, Zhang, Dorothy1, Parlow, Albert2, Glimcher, Laurie1, 2, 1 Department of Immunology and Infectious Diseases, Boston, MA2 National Hormone and Peptide Program, Torrance, CA
           Although inflammatory cytokines produced by the immune system are generally important in endocrine regulation, the possibility that immune activation might regulate the reproductive endocrine system during pregnancy and thereby influence reproductive success has not been directly evaluated. We describe a murine model of early pregnancy failure induced by systemic activation of CD40, an immune costimulatory molecule that plays a central role in the generation of adaptive and innate immune responses. Although fetal loss involved systemic inflammation and a natural killer cell intermediate, it was not due to lymphocyte-mediated destruction of the fetus and placenta. Rather, pregnancy failure resulted from impaired progesterone synthesis by the corpus luteum, a defect in turn associated with ovarian resistance to the gonadotropic effects of prolactin. Pregnancy failure also required the proinflammatory cytokine TNF-alpha, which likely acted directly on corpora luteal cells to induce the prolactin receptor signaling inhibitors SOCS1 and SOCS3. Links between immune activation and reproductive endocrine dysfunction may be relevant towards pregnancy loss and other clinical disorders of reproduction.


      PS2. TESTICULAR LEUKOCYTES AND CYTOKINES: INFLAMMATION AND IMMUNOREGULATION IN AN IMMUNE-PRIVILEGED TISSUE. Hedger, Mark1, 1 Monash University, Melbourne, VIC, Australia
           The testis comprises two separate compartments: the seminiferous tubules, containing the spermatogenic cells, and the interstitial tissue, containing the endocrine and vascular components. It is widely recognised that spermatogenic cells express a large number of potential auto-antigens, and consequently are highly susceptible to attack by the immune system. The immuno-protective mechanisms that normally prevent such deleterious responses in the testis are poorly understood. Although the blood-testis barrier separates the testicular compartments, spermatogenic cells are only partially sequestered by this barrier, and both leukocyte access and lymphatic drainage of the testis appear to be relatively unrestricted. Significantly, immuno-protection (or immune privilege) is extended to intratesticular grafts of foreign tissue, and the extended survival of such grafts appears to be due to inhibition of early immune activation events. The accumulated evidence indicates that both inflammatory and antigen-specific recognition responses in the testis are inhibited by specific immunoregulatory mechanisms. Much attention has focussed on the large population of resident macrophages in the testis, and it appears that many of these cells may possess a unique immunoregulatory or alternatively activated phenotype. Significant numbers of regulatory lymphocyte subsets, particularly NK T cells, are also present. These immune cells no doubt contribute to the restraint of local inflammation and immune activation responses. An alternative role for the testicular macrophages and lymphocytes, which include NK cells, in providing innate protection from infection and tumour development also is indicated. Finally, the somatic cells of the testis, most notably the Sertoli cells, produce a number of cytokines, lipids and membrane-bound ligands with imunoregulatory properties. Altogether, the data suggest that there exists a dynamic interaction between the testicular cells and immune system that benefits testicular function by suppressing autoimmunity without compromising normal innate immunity.



      Plenary Lectures

        Plenary Session I
        Monday, July 25, 2005
        8:00 AM–8:45 AM
        Location: CCQ 2000BC

        PL1. NUCLEAR-CYTOPLASMIC TUG-OF-WAR IN CLONING: OUTCOMES AND HANDICAPS. Latham, Keith1, 1 Temple University School of Medicine, Philadelphia, PA
             Successful cloning of mammals by somatic cell nuclear transfer requires that a somatic cell genome substitute for an embryonic genome in all respects. At the level of gene transcription, this implies the silencing of the donor cell genome followed by temporally correct execution of the embryonic program. Data thus far indicate that this process is quite slow. As a result, when transcription begins, the cloned embryo expresses numerous characteristics of somatic cells. These include specific molecular markers, as well as altered in vitro culture requirements. Another respect in which the donor genome must substitute for an embryonic genome is in the correct interaction with the cytoplasm in order to undergo efficient DNA replication and chromosome segregation during mitosis. Available data indicate that a number of the aberrant characteristics of cloned embryos are abrogated in tetraploid constructs prepared by performing SCNT without removal of the oocyte spindle chromosome complex (SCC). This indicates that the oocyte SCC contains factors that regulate other cellular processes besides chromosome segregation during cleavage, and that its removal deprives the embryo of these factors. Western blot analysis reveals that removal of the SCC prior to SCNT depletes the oocyte of a number of proteins, but many of these appear to be replenished over a short time period. Interestingly, somatic and embryonic donor nuclei differ in their ability to form SCC with the correct molecular composition. This may compromise the genomic integrity of a majority of SCNT embryos. The combination of mitotic errors and expression of somatic cell characteristics likely account in large measure for the poor efficiency of term development following SCNT.



        Plenary Session II
        Tuesday, July 26, 2005
        8:00 AM–9:00 AM
        Location: CCQ 2000BC

        PL2. ORIGIN AND FUNCTION OF MAMMALIAN FEMALE GERMLINE STEM CELLS. Tilly, Jonathan1, 1 Vincent Center for Reproductive Biology, Boston, MA
             Female reproductive aging is driven in large part by a progressive decline in the number of oocyte-containing follicles throughout life, which eventually leaves the ovaries barren of post-meiotic germ cells. Exhaustion of the oocyte pool not only heralds permanent infertility but also, by virtue of the importance of the oocyte to the function of the follicle, marked changes in ovarian hormone production. In human females these events culminate in the menopausal transition, a major turning point in the life of every woman that is associated with an increased risk for the development of a number of debilitating physical and psychological health problems. For many years, our understanding of ovarian failure has been firmly rooted in a single basic concept – unlike males of the species, female mammals are not provided with the luxury of a renewable germ cell pool. Accordingly, the endowment of oocytes set forth at birth represents a fixed reserve that simply erodes away to the point of exhaustion later in adult life. Although this one concept has dictated how essentially every aspect of ovarian development, function and failure has been approached for the better part of the past five decades, we recently provided evidence indicating that oocyte and follicle production in fact persist in adult female mammals (Nature 2004 428:145-150). We have since followed this work with a number of experiments in mice directed at isolating the replicative germ cells responsible for maintaining postnatal oocyte production. We have also tested the functionality of the resultant cell preparations for germline stem cell (GSC) activity by, among other things, transplantation into sterilized female recipients to confirm a rescue of de-novo oocyte production by the donor cells. Based on the data obtained thus far, which are fully supportive of the existence of female GSCs in mice, studies have been initiated to identify a comparable cell population in adult human females. Should these new experiments prove equally successful, this line of work may pave the way for the development of adult stem cell-based strategies aimed at restoring or prolonging ovarian function and fertility in women. (This work was supported by NIH R01-AG012279, R01-AG024999, the Rubin Shulsky Philanthropic Fund, and Vincent Memorial Research Funds).


        PL3. MINING FOR NEO-OOGENESIS IN THE MAMMALIAN OVARY: PAST, PRESENT, FUTURE. Albertini, David1, 1 Kansas University Medical Center, Kansas City, KS
             Recent studies in mice suggest that the ovary is able to generate postnatally new oocytes from a stem cell reserve. Public reaction to these findings has been broad based with respect to therapeutic management of the age-related loss of fertility in mammals. Within the scientific community, there is foremost a call to revisit the problem of neo-oogenesis especially since ovarian tissues, as with many other tissues, clearly exhibit regenerative potential in the somatic compartments but with rare exceptions, not within the germ line. This presentation will review the history of studies on neo-oogenesis with respect to the reproductive strategies engaged by mammalian and submammalian organisms.More contemporary approaches, including selection of appropriate markers for cell cycle dynamics in intact and sectioned materials will be considered in the context of stereological analyses using living versus fixed materials. Finally, the notion of stemness in the ovary is considered with respect to regenerative capacities segregated into soma and germ line in developmentally distinct paradigms that may in the future be approached by genetic manipulation and in vitro strategies.



        Plenary Session III
        Wednesday, July 27, 2005
        8:00 AM–8:45 AM
        Location: CCQ 2000BC

        PL4. PROTEIN FOLDING: IMPLICATIONS FOR REPRODUCTIVE DISEASES. Conn, P. Michael1, 1 Oregon National Primate Research Center, Beaverton, OR
             The GnRH receptor (GnRHR) is a heptahelical G protein coupled receptor (GPCR) found in the plasma membrane of pituitary gonadotropes. GnRHR mutants isolated from patients with hypogonadotropic hypogonadism (HH) are frequently mislocalized proteins; the vast majority of these (12 of the 15 point mutations reported) can be restored to function by peptidomimetic antagonists, acting as pharmacological chaperones or "pharmacoperones." Structure-activity relations have been described for members of three different chemical classes of pharmacoperones. In addition to naturally occurring mutations, "designer" mutants replacing Cys (needed for stabilization of the tertiary structure of the receptor) by Ala, or internal deletions or truncations, can also be rescued by this approach or by alterations in the genetic sequence of the receptor. Non-functional HH mutants also inhibit ligand binding and ligand activated second messenger production by wild type receptor when both are co-expressed in vitro. Confocal microscopy shows that this "dominant-negative effect," (which occurs for human but not for rodent GnRHR), results from wild type receptor retention in the endoplasmic reticulum by mislocalized mutants. Pharmacoperones also rescue the wild type receptor from retention. Because of the large number of human diseases that appear to be caused by defective protein folding and subsequent mislocalization, it is likely that endoplasmic reticulum retention is a common cause of dominant-negative actions for other diseases involving GPCRs, as appears to be the case in HH and for which there exists a potential therapeutic agent. (Supported by: HD-19899, RR-00163, TW/HD-00668 and HD-18185). References: 1. Conn, P.M., Leanos-Miranda, A and Jo Ann Janovick, J. Molecular Interventions 2 (5): 308-316, 2002. 2. Janovick, J., Goulet, M., Bush, E. Greer, J, Wettlauffer, D, and Conn, P.M., J. Pharmacol. Experimental Therapeutics, 305(2): 608-614, 2003 3. Janovick, J.A., Maya-Nunez, G., Conn, P.M. J. Clin. Endocrinol. Metab. 87(7):3255-3262, 2002 4. Leanos-Miranda, A, Janovick, J and Conn, P.M, J. Clin. Endocrinol. Metab. 87(10): 4825-4828 2002. 5. Brothers, S.P. and Conn, P.M., J. Clin. Endocrinol. Metab.88: 6107-6112, 2003. 6. Leanos-Miranda, A, Ulloa Aguirre, A , Ji, T.H., Janovick, J., Conn, P.M., , J Clin Endocrinol Metab 88: 3360-3367, 2003. 7. Janovick, J, Ulloa-Aguirre, A and Conn, PM, Endocrine 22(3):317-328, 2003. 8. Brothers, S.P., Cornea, A, Janovick, J.A. and Conn, P.M., Molecular Endocrinology 18 (7): 1787-1797 (2004), July 2004). 9. Ulloa-Aguirre, A., Janovick, J., Leanos-Miranda, A., Conn, P. M., , Expert Opinion on Therapeutic Targets, 7(2):175-185, 2003. 10. Ulloa-Aguirre, A., Janovick, J.A., Leanos-Miranda, A., and Conn, P.M., Human Reproduction Update, 10 (2): 177-192, 2004, 2004. 11. Ulloa-Aguirre, A., Janovick, J., Brothers, S. and Conn, P.M., Pharmacological Rescue of Conformationally-Defective Proteins: Implications for the Treatment of Human Disease, Traffic 5: 821-837, 2004 published online 8-Oct-2004 (cover image). 12. Castro-Fernandez, C, Maya-Nunez, G and P. Michael Conn, Beyond the Signal Sequence: Protein Routing in Health and Disease, manuscript in press, published online November 8, 2004; Endocrine Reviews, 2005. 13. Leanos-Miranda, A., Ulloa-Aguirre, A., Janovick, J.A. and Conn, P.M., In Vitro Coexpression and Pharmacological Rescue of Mutant GnRH Receptors Causing Hypogonadotropic Hypogonadism in Humans Expressing Compound Heterozygous Alleles. In press, J Clin Endocrinol Metab 2005.



      Trans-Atlantic Exchange Lectures
      Tuesday, July 26, 2005
      4:30 PM–6:00 PM
      Location: CCQ 2000BC

      EX1. A MOLECULAR APPROACH TO SEMEN CRYOPRESERVATION: NEW TECHNOLOGIES TO ANSWER OLD QUESTIONS. Thurston, Lisa1, Michael, Anthony2, Watson, Paul1, Holt, William3, 1 Royal Veterinary College, London, UK2 University College London, London, UK3 Institute of Zoology, London, UK
           Although semen cryopreservation has been applied successfully in a few species, considerable variation in post-thaw semen viability exists. Independent of sperm quality before freezing, the semen of certain individuals will consistently freeze badly, resulting in poor motility, disrupted acrosome and plasma membrane, and thus reduced fertilising ability, indicating the existence of variation in membrane properties within species. A more comprehensive understanding of sperm cryobiology would be obtained by the investigation of within-species variation in the susceptibility of spermatozoa to cryoinjury. The aim of this work is to explore the phenomenon of consistent variation in frozen semen quality between species and between individuals in an effort to find new insights into the reasons for cryoinjury. We suggest that there is a genetic basis for variation in post-thaw semen quality. Using modern molecular technologies such as amplified restriction fragment polymorphism (AFLP) we were able to identify 16 markers linked to genes influencing variation in semen freezability. The identification of genetic differences between individuals, which may be linked to cryosurvival, provides an opportunity to develop a functional and molecular understanding of the factors that influence semen cryopreservation, allowing selective breeding of desired traits and the development of genetic tests that predict the outcome of semen freezing.


      EX2. THE ROLE OF GATA FACTORS IN MAMMALIAN REPRODUCTIVE FUNCTION. Viger, Robert1, 1 CHUL Research Center, Laval University, Ste-Foy, QC, Canada
           GATA transcription factors were originally identified as crucial regulators of heart development and hematopoietic cell differentiation. GATA factors, however, are not unique to these two systems but rather are expressed in a wide variety of tissues including the testis and ovary. As little as five years ago, the role of GATA factors in reproductive function was uncharted territory. Since then, we and others have come a long way in filling this void. GATA factors have now been implicated in gonadal development, male sex determination and differentiation, and steroidogenesis. Our insights into these roles have come mainly from the identification of novel GATA-dependent gene promoters. This growing list includes genes that code for hormones (MIS/AMH, inhibin alpha), steroidogenic enzymes (StAR, HSD3B2, CYP19), and transcription factors (DMRT1, SRY). Thus, GATA factors appear to play a central role in mammalian reproductive function. Their regulation and mechanism of action, however, have yet to be fully understood. The specificity of GATA action is controlled in part, via protein-protein interactions with other transcriptional partners. Indeed, our original studies showed that GATA4 regulates MIS gene transcription in cooperation with steroidogenic factor 1 (SF-1). We now have data that GATA4 also regulates SRY transcription through a similar cooperation, not with SF-1, but with Wilms tumor 1 (WT1). Another mechanism for regulating GATA function is through post-translational modification of GATA proteins. We have previously identified GATA4 as an effector of hormone action in gonadal cells via cAMP/PKA signaling and phosphorylation of GATA4. We now have evidence that GATA4 is also phosphorylated by MAP kinase but on a different set of amino acids. Elucidation of the in vivo role played by GATA factors in the gonads has been hampered by the embryonic-lethal phenotype of GATA knockout mice. To overcome this problem, we have generated a novel transgenic mouse model where endogenous GATA function is knocked-down by tissue-specific overexpression of a GATA dominant negative competitor. When targeted to postnatal Sertoli cells, mice are infertile due to a late block in spermatogenesis. A description of this knockdown model and our other recent data on the role GATA factors in reproductive function will be presented.



      Techniques in Reproductive Biology Workshop: Methods of Whole-Animal and Whole-Cell Imaging
      Sunday, July 24, 2005
      7:30 AM–1:00 PM
      Location: CCQ 206AB

      TW1. Visualization of Biochemical Networks in Living Cells. Michnick, Stephen1, 1 Université de Montréal, Montreal, QC, Canada
           The overall aim of our research is to develop and apply experimental, informatic and theoretical approaches to understanding the evolutionary origins and existing organization of biochemical networks. Cellular biochemical networks consist of dynamically assembling and disassembling macromolecular complexes. While our models for the organization of biochemical machines are derived largely from in vitro experiments, do they reflect their organization in intact, living cells? To address this challenge we have developed a general experimental strategy allowing for quantitatively probing the dynamics of molecular interactions in intact, living cells. The strategy is based on Protein fragment Complementation Assays (PCA) , a method whereby protein interactions are coupled to refolding of enzymes from cognate fragments where reconstitution of enzyme activity acts as the detector of a protein interaction. A dynamic biochemical network is defined by grouping interacting proteins into those that are perturbed in the same way by common factors (hormones, metabolites, enzyme inhibitors, etc) in a similar manner to which transcriptional profiles are used to deduce genetic programs. We are seeking to go from descriptive to quantitative representations of biochemical networks at an individual to whole genome level. Our ultimate aim is better descriptions of the biochemical machineries that underlie living processes.


      TW2. MULTI-PHOTON EXCITATION FLUORESCENCE MICROSCOPY, IN VIVO. Balaban, Robert1, 1 National Heart Lung and Blood Institute, NIH, Bethesda, MD
           Two-photon excitation fluorescence microscopy (TPEFM) (Denk et al., 1990) permits the monitoring of subcellular events in thick samples as well as living animals. TPEFM relies on the use of infrared light (IR) to penetrate deep into tissues generating essentially visible or ultraviolet light at the focal point of an appropriate microscope lens to excite intrinsic or added fluorophores inside the tissue. The detection of the fluorescence is then usually done in a conventional manner. In addition, structural information on the tissue can be obtained from multiple harmonic generation from the IR photons, providing information on the chemistry and structure of intrinsic elements in the tissue. The remarkable aspect of this approach is that the high spatial resolution of this approach (1x1x2 microns) deep in the tissue permits the observation of intracellular events in vivo. This provides a unique opportunity to use approaches in cell biology that have generally been limited to the Petri dish to true in vivo conditions. These approaches have been applied to the study of mouse and rabbit skeletal muscle, in vivo. The technical details and challenges of making these measurements on the micron scale in a living animal will be discussed and illustrated. These include significant modifications to the microscope for use in small and large animals as well as the preparation of the animal. A review of the information content currently available using this approach will be provided using the in vivo skeletal muscle as an example. This information includes cellular topology, vessel structure, microvascular flow, collagen deposition, mitochondria distribution and redox state, oxygenation, and many other important structural and functional elements. The potential use of these approaches in developmental studies on different spatial and temporal scales will be discussed with specific examples.


      TW3. MICROSCOPY AND ITS APPLICATION IN THE STUDY OF PROTEIN : PROTEIN INTERACTION IN VIVO. Centzone, V1, Krishnan, R, Zhang, J-H1, Herman, B1, 1 University of Texas Health Science Center, San Antonio, TX
           Optical sectioning microscopy techniques such as confocal and multiphoton microscopy have provided significant improvements in z resolution thus enabling better detection of the juxtaposition of proteins in biological material. Such information has resulted in a better understanding of the 3-dimensional architecture of cells and tissues. Determination of whether proteins interact on a molecular level requires that the resolution of the light microscope be extended to the level nanometer scale. While some highly sophisticated imaging systems can approach this level of resolution it is beyond the capabilities of the normal light microscope. However, techniques such as Fluorescence Resonance Energy Transfer (FRET) can be employed to detect proximity of proteins within 10 nanometers thus inferring molecular interaction. Several methods of FRET have been successfully employed using conventional confocal and multiphoton microscopes, sensitized emission, acceptor photobleaching and Fluorescence Lifetime Imaging Microscopy (FLIM). Recent advances in these methods in both fixed and living cells and tissues will be presented.



      Historical Perspectives Lecture
      Monday, July 25, 2005
      7:15 AM–8:00 AM
      Location: CCQ 2000BC

      HP1. DISCOVERY OF THE NUCLEAR ESTROGEN RECEPTOR: A HISTORY LESSON. Gorski, Jack1, 1 University of Wisconsin, Madison, WI
           The concept of receptors goes back to the beginning of the last century but their first experimental demonstration came in the 1950s from the elegant work of Elwood Jensen and his colleagues. He developed novel methods for Tritium labelling and counting of high specific activity estrogens. Jensen's work displaced the popular transhydrogenase theory of steroid hormone action by showing that active estrogens were not metabolized in the course of their function. The transhydrogenase theory required the oxidation/reduction of the steroid in the process of transfering reducing equivalents between classes of pyridine nucleotides. Two major additions to Jensen's work included Noteboom's 1960s study of the subcellular distribution of the the estrogen receptor after injecting physiological quantities of estrogoen. The large amounts of nuclear estrogen receptor focused attention on the nucleus as the site of estrogen action. The isolation and initial characterization of the estrogen recepto was carried out by Toft who used density gradient centrifugation to first isolate the soluble receptor. These early studies coupled with Notides' work on the estrogen inductoon of a specific uterine protein led to the development of a model of estrogen action in which the nuclear estrogen receptor interacts with chromatin proteins resulting in a specific wave of gene inductions and subsequently a change in the physiolgical state of the target cell.



      Trainee Forum: Writing Winning Grant Proposals: Formulas for Success
      Chair(s): Salli, Ugur1, 1 Penn State College of Medicine, Hershey, PA
      Tuesday, July 26, 2005
      12:45 PM–1:45 PM
      Location: CCQ 206A

      TF1. WRITING WINNING GRANT PROPOSALS: FORMULAS FOR SUCCESS. Mirando, Mark1, 1 National Research Initiative Competitive Grants Program, Washington, DC
           In today's 'publish or perish' academic world, obtaining extramural funding support is requisite to developing and maintaining a focused research program that will allow for professional advancement, including promotion and tenure. In fact, many announcements for available faculty positions often include demonstrated ability to attract extramural funding as a criterion for applicants to be considered for these positions. However, many graduate student and postdoctoral trainees enter the job market with limited experience in preparation of grant proposals. Preparation of successful grant proposals typically requires a combination of experience, skill and persistence. Lack of initial success can be especially frustrating for new faculty who are novices at the art of proposal preparation and unfamiliar with the review process. Success at writing proposals and obtaining grants can be improved by following a few simple but important guidelines. These include obtaining experience by getting involved in proposal preparation as trainees, developing ideas for proposals based on the individual funding program's priorities that are published in the request for applications (RFA), understanding how the proposal review process works, preparing the application well in advance of the proposal receipt deadline and obtaining critical review of the proposal draft from colleagues that have been successful at obtaining grants. Finally, applicants must follow the rules for submission of the proposal, as specified in the RFA. These include adherence to guidelines for page limits, font size and margins, inclusion of all required sections and information, and submission of the application in a timely fashion such that it arrives at the funding agency before the receipt deadline. This presentation will discuss the proposal review process, attributes of successful grant proposals and mistakes commonly made during preparation and submission of unsuccessful proposals. It will serve as a useful refresher for those more experienced at proposal preparation, as well as provide information for the novice proposal writer.



      Minisymposia

        Minisymposia I-V
        Monday, July 25, 2005
        9:00 AM–10:30 AM

          Minisymposium I. Threats to Reproductive Success in a Modern World
          Chair(s): Guillette, Louis1, 1 University of Florida, Gainesville, FL
          Location: CCQ 205ABC

          MS1. GENES VERSUS ENVIRONMENT, AND REPRODUCTIVE SUCCESS IN ENDANGERED SPECIES. Wildt, David 1, Pukazhenthi, Budhan1, Ballou, Jonathan1, Pelican, Katharine1, Howard, JoGayle1, 1 Smithsonian's National Zoological Park, Conservation & Research Center, Front Royal, VA
               More than 23% of mammals, 12% of birds, 4% of reptiles and 32% of amphibians worldwide are listed as "threatened" by the IUCN-World Conservation Union. For the vast majority of all species, there is inadequate data on fundamental biology – absolutely essential information for developing scientifically sound programs to preserve and conserve species and habitats. Recovery plans for listed species prepared by the U.S. Fish & Wildlife Service under the Endangered Species Act call for hundreds of studies and management actions (including captive-breeding) to achieve recovery and to allow delisting. Zoos also are in crisis and are inadequately equipped to manage sustainable populations that serve as genetic reservoirs for species in nature. For the reproductive sciences, there are three risks related to rare wildlife species and populations. The first simply is too little scholarly knowledge, with less than 3% of mammals studied and even lower percentages for birds, reptiles, amphibians and fish. The second danger is loss of genetic variation due to habitat fragmentation for wild populations and suboptimal management of ex situ collections. There are ramifications on morphometrics and physiological function, although the eventual impact on reproductive success remains unclear. The third risk is imposed by the environment itself. Although much remains to be learned about "perturbing factors" in nature, it is apparent that enriched captive environments promote reproductive success. Examples of impact and approaches for dealing with these threats will be addressed using experiences from our laboratory that include the Florida panther, black-footed ferret, clouded leopard and giant panda. The reproductive sciences as a discipline are well positioned to make a difference in studying and mitigating threats to reproductive success for wildlife, including endangered species. Our goal is to inspire others to become more involved because few challenges are more important, rewarding or necessary.


          MS2. RISKS ASSOCIATED WITH ASSISTED REPRODUCTION: MECHANISTIC INSIGHTS FROM ANIMAL STUDIES. Sinclair, Kevin1, Young, Lorraine2, 1 Centre for Reproduction and Early Life, Loughborough, UK2 Division of Obstetrics and Gynaecology, Nottingham, UK
               Modern techniques in assisted reproduction (ART) have become a common and accepted form of clinical care benefiting an estimated one in ten people of reproductive age who are sub-fertile or infertile. The success of these technologies is due largely to the remarkable tolerance of mammalian gametes and the pre-implantation embryo to physical manipulations and alterations to their chemical environment. Recent reports from both human and animal studies, however, suggest that our faith in the ability of these germ cells to accurately recapitulate the normal process of early development under such conditions may be misplaced. Whilst acknowledging the recognized risk factors of increased maternal age and infertility in human ART subjects, and the transfer of supernumery embryos, evidence from animal studies indicates that ART procedures can directly contribute to the variable perinatal outcomes observed and imprinting disorders recently recognized. Controversy surrounds the specific nature and extent of these contributions but ovarian stimulation, in vitro maturation and embryo culture, cytoplasmic transfer, ICSI and gamete/embryo cryopreservation have all been implicated. It is known, for example, that superovulation can reduce implantation rates and the development of surviving pups in mice; that ICSI can lead to abnormal nuclear remodeling in non-human primates; and that extended periods of embryo culture can result in the Large Offspring Syndrome in ruminants. There is increasing evidence to directly link early embryonic manipulations to epigenetic modifications of DNA, which in some instances can alter genomic imprinting. Perhaps this is unsurprising, since we know that following erasure of germline methylation imprints in primordial germ cells, sex-specific imprints are re-established during the latter stages of gametogenesis, a period coincident with many ART procedures. Furthermore, there are additional major phases of epigenetic reprogramming around the time of syngamy, involving species-specific genome-wide losses of DNA methylation, and during pre-implantation development, involving locus-specific de novo methylation, both of which may be vulnerable to environmental influences. We are currently seeking to understand these relationships and the effects of maternal nutrition.


          MS3. PARALLEL ASSESSMENT OF TESTICULAR FUNCTION OF WORKERS AND WILD RAT (Rattus rattus) EXPOSED TO PESTICIDES IN A BANANA PLANTATION. Multigner, Luc1, Pascal, Michel2, Kadhel, Philippe3, Jegou, Bernard1, 1 University of Rennes, Rennes, France2 INRA, Rennes, France3 CHU, Pointe à Pitre, Pointe à Pitre, Guadeloupe
               This study aimed at assessing the effect of pesticides currently employed in banana plantations on testicular function of workers and wild rats. Methods: We performed a cross-sectional study to assess semen quality and serum of reproductive hormones in workers. A physical and andrological examination was carried out and men gave a semen and blood samples. An interview was conducted to obtain the required information. Andrological examination and semen evaluation were performed according to WHO. Serum was analysed for hormones. Forty-five of the subjects were professional pesticide applicators and 42 worked in non-agricultural sectors (control group). Wild rats were captured at 2 sites: the pesticide-exposed site represented by the same banana plantation as the one covered by the workers part and a pesticide-free site. Blood samples were collected. At autopsy, body and reproductive organ weights were recorded. Sperm reserves were determined. Serum was analysed for testosterone. Results: Workers: After adjustment for condounding factors, we found that a sperm output of below 40 millions was slightly associated with having over 14 years occupational exposure. Rats: When testis and epididymis weights were adjusted for the difference in body weight the latter appeared significantly lower in the banana plantation. Furthermore, both the total sperm reserves (adjusted for body weight) and the testosterone levels were also significantly lower in the polluted site versus to the unpolluted one. Conclusion: Application of pesticides to banana crops is not associated with significantly altered sperm quality or testicular hormone concentrations, except in men who have applied pesticides for many years where a marginal alteration of sperm quality may have occurred. A significant alteration of several productive parameters was noticed in the pesticide exposed wild rats.



          Minisymposium II. Non-Genomic Actions of Sterioids in Reproductive Tissues
          Chair(s): Stormshack, Fredrick1, 1 Oregon State University, Corvallis, OR
          Location: CCQ 2000A

          MS4. MEMBRANE ACTIONS OF SEX STEROIDS IN NEURONS: IMPLICATIONS FOR GENOMICS AND BEHAVIOR. Vasudevan, N.1, Kow, L1, 1 The Rockefeller University, New York, NY
               Historically, genomic and membrane actions of steroid sex hormones were thought to be alternatives to each other, mechanistically unrelated and controversial. However, in a neuroblastoma cell line, we found that membrane-initiated actions of an estrogen could actually potentiate later genomic actions mediated by a consensus ERE (PNAS, 2001). The data offer the possibility of a unified view of estrogenic action in nerve cells. Multiple signal transduction systems are involved in this phenomenon, with the interesting characteristic that some are both necessary and sufficient. The membrane action's facilitation of estrogen actions in the nucleus holds true in hypothalamic neurons, as demonstrated by mating behavior measurements (PNAS 2004). Surprisingly, thyroid hormone can substitute for estradiol in the first pulse (PNAS, 2005). Both the logic and the quantitative features of sex hormone actions in neuronal membranes are more complex than anticipated.


          MS5. SIGNALING PATHWAYS ACTIVATED BY NON-GENOMIC EFFECTS OF ESTRADIOL. Santen , Richard 1, Song , Robert 1, 1 University of Virginia, Charlottesville, VA
               Breast cancer cells provide a model to examine the disparate effects of estradiol (E2) acting to initiate nuclear transcription and to modulate plasma membrane growth factor signaling. To gain a better understanding of the membrane component, studies focused upon the rapid (i.e. 1-15 minute) actions of E2 on growth factor signaling pathways. E2 activates MAP kinase and Akt in breast cancer cells within 5-10 minutes, suggsting non-genomic mechanisms of ER alpha (ER). Our studies demonstrated that the adaptor protein Shc is required for MAP kinase activation. E2 causes phosphorylation of Shc through Src, binding of Shc to Grb-2 and to SOS. In the process, Shc binds to ER. E2, after binding to ER, appears to co-opt growth factor signaling pathways that activate MAP kinase and PI-3-kinase. We questioned how how ER anchors in the membrane since it does not have a membrane localization signal. It appears that Shc serves as the bus which transports ER to the membrane. After phosphorylation, Shc binds to ER but it also physically interacts with the IGF-1 receptor (IGF-1R). We reasoned that ER, when bound to Shc, would be directed to the region of the membrane by the same processes causing Shc to translocate to growth factor receptor proteins. Accordingly, we examined the role of Shc and IGF-1R in mediating ER membrane association in MCF-7 cells. We initially confirmed that E2 rapidly induced IGF-1R phosphorylation and then demonstrated that E2 induced a ternary protein complex formation among Shc, ERa and IGF-1R. The functionality of Shc in this process was demonstrated by experiments down-regulating Shc with a selective siRNA. Confocal microscopy studies provided confirmation of the functional roles of Shc and the IGF-1R in the translocation of ER to the region of the membrane. We first demonstrated that E2 caused co-localization of ER, Shc and IGF-1-R to the membrane and then showed that knock down of either Shc or IGF-1R abolished this effect. Down-regulation of Shc, ERa or IGF-1R with specific siRNAs all blocked E2-induced MAPK phosphorylation. Together our results demonstrated that Shc and IGF-1R serve as key elements in the translocation of ER to the cell membrane and in the facilitation of ER-mediated rapid E2 action. These events appear to be important in mediating the proliferative effect of E2 on breast cell growth.


          MS6. IDENTIFICATION OF A PUTATIVE PROGESTERONE RECEPTOR COMPLEX AND SIGNAL TRANSDUCTION PATHWAY THAT MEDIATES PROGESTERONE'S NON-GENOMIC ACTION IN RAT GRANULOSA AND LUTEAL CELLS. Peluso, John1, 1 University of CT Hlth Ctr, Farmington, CT
               Granulosa cells of several species only express nuclear progesterone receptors (nPRs) for a few hours after the LH surge. Since progesterone (P4) inhibits apoptosis of granulosa cells before and after the LH surge, the receptor that mediates P4's anti-apoptotic action remains to be determined. In spontaneously immortalized granulosa cells (SIGCs), which do not express nPRs, the protein, RDA288, appears to mediate P4's action. This is based on the observations that forced expression of RDA288 increases P4 binding and responsiveness. Moreover, an antibody to RDA288 attenuates P4's anti-apoptotic action in SIGCs as well as freshly isolated rat granulosa and luteal cells. Finally, RDA288 localizes to the extracellular surface of the plasma membranes of these cells, suggesting a membrane site of action. However, RDA288 does not have a transmembrane domain. This implies that RDA288 must interact with a transmembrane protein to form a functional membrane receptor complex. Immunoprecipitation studies reveal that RDA288 interacts with the membrane P4 binding protein, Progesterone Membrane Receptor Complex-1 (PGMRC-1, rat homolog accession number AJ005837). Treatment with an antibody to PGMRC-1 blocks P4's actions. PGMRC-1 like RDA288 localizes to the extracellular surface of the plasma membrane. These findings are consistent with a non-genomic membrane-initiated site action for P4. This non-genomic action is confirmed by P4's ability to increase protein kinase G (PKG) activity within minutes. Using a proteomic approach we have identified 14-3-3 as one of many downstream targets of P4-activated PKG. Taken together, these studies suggest that P4 binds to a membrane complex composed of RDA288 and PGMRC-1. P4 binding triggers membrane initiated events that activate PKG and subsequently many PKG downstream targets including 14-3-3. This P4-regulated signal cascade accounts in part for P4's anti-apoptotic action.



          Minisymposium III. Determinants of Preimplantation Embryonic Development
          Chair(s): Hansen, Peter1, 1 University of Florida, Gainesville, FL
          Location: CCQ 206B

          MS7. DEVELOPMENT AND ASSESSMENT OF THE HUMAN EMBRYO. Gardner, David1, Katz-Jaffe, Mandy1, 1 Colorado Center for Reproductive Medicine, Englewood, CO
               There exists a false impression that human embryos do not develop well in vitro compared to the embryos of other mammalian species. Evidently the main reason for this is that the vast majority of human embryology has stemmed from work on patients who are, by default, infertile and therefore already have some problems associated with either fertilization or embryo development. However, through oocyte donation programs it is possible to utilize human oocytes from young fertile women. In an oocyte donation program 65% of fertilized oocytes develop to the blastocyst stage. When such embryos are transferred to recipient uteri, implantation rates of greater than 65% are attained, with an ongoing pregnancy rate of over 80% when two blastocysts are transferred. Typically human embryos are cultured in stage specific media under a reduced oxygen environment. Several morphological scoring systems have been developed in an attempt to select the more viable embryos from within a given cohort. Parameters that are associated with increased embryo viability include early cleavage of the zygote, minimal fragmentation and the appearance of mononucleated blastomeres on day 2 and 3, symmetry of the blastomeres, and the formation of a blastocyst with a well developed inner cell mass. Other, non morphological, systems of assessing embryo viability currently in use include the biopsy of a blastomere on day 3 to determine the karyotype of up to 9 chromosomes using FISH. This approach of genetic screening will be superceded by techniques like array CGH that will be able to determine the whole chromosome complement. Analysis of media samples is currently being used to determine carbohydrate and amino acid utilization, together with the measurement of specific factors such as HLA-G. The relationship between metabolism and embryo viability is currently being determined in prospective clinical trials. Furthermore, with the advent of proteomics to the field of IVF, protein profiles of viable embryos and culture media could also lead to the development of viability assays. All of these methods of embryo assessment, together with better culture conditions, are leading to single embryo transfer for IVF patients, thereby alleviating the problems associated with multiple births.


          MS8. DEVELOPMENTAL CONSEQUENCES OF SEXUAL DIMORPHISM FOR GENE TRANSCRIPTION DURING PREIMPLANTATION EMBRYONIC DEVELOPMENT. Gutierrez-Adan, Alfonso1, 1 INIA, Madrid, Spain
               Preimplantation embryos are susceptible to environmental conditions that can affect future growth and developmental potential. In ruminants, an example of embryo sensitivity is the large offspring syndrome produce by in vitro culture (IVC). However, abnormalities in developmental potential arising from preimplantation environment are not limited to IVC and may be consequence of specific stress conditions experienced in vivo, like maternal diet that may affect in a gender-specific manner. A complex of mechanisms (gene expression, epigenetic, metabolic, etc) may operate to relate early embryo environment with future health. Moreover, during preimplantation period, male embryos in vitro produced have a higher metabolic rate and grow faster than females. It has been also described differential gene transcription between males and females for genes located in the chromosome Y (SRY, ZFY), in the X (G6PD, HPRT, XIAP), or in autosomal (IF). These differences produce that according with gender; embryos may be affected differentially by environmental conditions. It has been suggested that under some stress conditions male embryos are more vulnerable than females; however the biological fragility of male embryos is little understood. Because most forms of stress result in the overproduction of cellular reactive oxygen species (ROS), we addressed the hypothesis that the connection between female advantage at early developmental stages and heat stress involves ROS and differential gene expression of some X-linked genes related to oxidative stress (i.e. G6PD). We found that after compaction, female embryos survive better than male under in vivo and in vitro heat stress situations. Also, the inhibition of G6PD reduces many of the differences observed between genders. This differential sort term response to the damaging effects of heat stress-induced ROS, may be due to gender differential G6PD expression. G6PD is the only NADPH-producing enzyme activated in response to oxidative stress, which can act as a guardian of the cell embryo redox potential. By following the differences between male and female embryos, it may be possible to gain further insight into, not only sex ratio distortion, but also aspects of early embryo development, X inactivation, and epigenetic and genetic process related with early development.


          MS9. THE OOCYTE AS A REPROGRAMMING MILIEU. Solter, Davor1, Evsikov, Alexei2, Peaston, Anne2, de Vries, Wilhelmine2, Holbrook, Andrea2, Knowles, Barbara2, 1 Max-Planck Institute for Immunobiology, 79108 Freiburg, Germany2 The Jackson Laboratory, Bar Harbor, ME
               Nuclei from differentiated somatic cells can be reprogrammed to totipotency in the oocyte milieu during the oocyte to embryo transition. Little is known about the mechanisms responsible for reprogramming, prompting us to investigate both the molecules and molecular mechanisms controlling this unique time in development. Once the oocyte is full grown, transcription ceases so that the oocyte to embryo transition is accomplished by utilizing stored maternal messages. Many maternal transcripts contain 3′UTR motifs responsible for controlled translation. Homologues of factors,described in non-mammalian cells, which bind to specific cis-sequences in the 3′UTR of mRNAs, are plentiful in the mouse oocyte and early embryo. Stage-specific availability of mRNas for translation sets the stage for dynamic molecular change in transcriptional silence. In addition, expression of discrete endogenous retroviral elements varies during the oocyte to embryo transition and may change expression of adjacent genes. These mobile elements affect gene evolution and may play a role in epigenetic restructuring of the embryonic genome. In fission yeast, retrotransposon expression triggers an RNA inhibition (RNAi) response, silencing the retrotransposon and leading to heterochromatinization of its genomic region. We speculate that the stage-specific activation of retrotransposons in mammalian oocytes and early embryos similarly initiates RNAi-mediated retrotransposon silencing and chromatin remodeling of their genomic loci and adjacent regions.



          Minisymposium IV. Biology of Male Germline Stem Cells
          Chair(s): Cupp, Andrea1, 1 University of Nebraska, Lincoln, NE
          Location: CCQ 204AB

          MS10. GERM CELL TRANSPLANTATION AND TRANSGENESIS IN PIGS AND GOATS. Dobrinski, Ina1, 1 Center for Animal Transgenesis and Germ Cell Research, Kennett Square, PA
               Transplantation of genetically modified germ cells to the testis of a recipient animal can result in production of transgenic sperm and offspring and is an alternative to currently inefficient transgenic technology in domestic species. Germ cell transplantation was first reported in mice. Xenogeneic spermatogenesis in mice did not occur with germ cells from donor species other than rodents. Therefore, homologous recipient models were established in domestic animals. Due to different testicular anatomy in rodents and large animals, germ cells cannot be delivered by the same technique. Instead, ultrasound-guided cannulation of the rete testis with low pressure cell delivery was successful in pigs, goats, and subsequently cattle. A transgenic goat born after transplantation of transgenic donor cells and mating of a recipient buck to a wild-type doe carried the same transgene integration pattern as the donor, providing proof of donor-derived sperm production, fertility, and transmission of a stable genetic germ line modification. While immunological tolerance between donor and recipient is required in rodents, transplantation was successful between unrelated, immuno-competent pigs or goats. Efficiency of engraftment can be further increased by depletion of recipient germ cells and enrichment of donor cells for stem cells. Local irradiation of the testes or in utero exposure to busulfan reduces endogenous germ cell numbers without irreversibly damaging the testis environment. While cell populations enriched in stem cells have been harvested from rodents with induced cryptorchidism by flow sorting for expression of cell surface antigens, the need for larger cell numbers make enrichment based on differential adhesion of germ cells a more practicable approach in pigs and goats. Work is now directed at establishing efficient culture systems allowing selection and expansion of germ cells with stable transgene integration. Transgenic rodents have been generated by viral transduction of germ cells prior to transplantation. Use of a viral vector to introduce a transgene into porcine and caprine germ cells has also shown promising results. Development of improved in vitro systems for targeted germ cell transduction will make germ cell transplantation a viable approach to transgenesis in domestic species.


          MS11. GERM STEM CELL MATURATION AND TRANSPLANTATION IN MICE AND BOVINE. McLean, Derek 1, 1 Washington State University, Pullman, WA
               Spermatogonial stem cells are responsible for the continual production of spermatozoa throughout the adult life. Interactions between spermatogonial stem cells and the surrounding cells in the seminiferous tubules regulate the biological activity of these cells. Factors involved in the regulation of SSCs are beginning to be defined by animal models and culture of SSCs in defined medium. A critical development in the characterization of SSCs has been the development of the germ cell transplantation technique. This technique provides the only assay for the presence of SSCs in a population of cells thereby affording scientists the ability to determine if SSCs are proliferating or differentiating in culture. Our lab has been using this technique to characterize factors that regulate the biological activity of spermatogonial stem cells from mice and bulls. Bovine SSCs can be cultured as dispersed cells on a bovine embryonic fibroblast (BEF) feeder layer or as tissue explants. Culture of dispersed bovine SSCs on the BEF feeder layer indicated that SSCs need glial cell line-derived neurotrophic factor (GDNF) for self-renewal but not differentiation. The BEF cell line produces GDNF to support the SSC such that exogenous GDNF is detrimental to SSC self-renewal. The bovine SSC population will also undergo self-renewal when bovine testis tissue explants from 4-week old bull calves are cultured on floating filters for 1 week. This system maintains cellular interactions between germ and somatic cells and can be used to evaluate the effect of factors on SSC differentiation and self-renewal. Mouse SSCs are also cultured on a feeder layer of mouse embryonic fibroblasts STO cells. Like the BEF cells, STO cells provide factors required for SSC self-renewal. In addition, several exogenous factors are required for mouse SSCs to undergo self-renewal in vitro including GFRa1, bFGF and GDNF. We have used microarrays to analyze gene expression in both BEF and STO cells to identify additional factors regulating SSCs. Culture and transplantation of SSCs has accelerated the pace of research of SSCs and promises to provide a better understanding of the factors and mechanisms that regulate these cells.


          MS12. AGE-DEPENDENT DIFFERENCE IN THE COLONIZATION ABILITY OF MOUSE SPERMATOGONIAL STEM CELLS AFTER TRANSPLANTATION. Nagano, Makoto1, Ebata, Kevin1, Zhang, Xiangfan1, 1 McGill University, Montreal, QC, Canada
               Spermatogenesis and its founder cells, spermatogonial stem cells (SSCs), appear to exhibit different characteristics in an age-dependent manner. For example, spermatogenesis occurs only for the first cycle after birth in juvenile spermatogonial depletion mutant mice, and immature mouse SSCs divide more actively than adult SSCs. In this study, we examined a hypothesis that immature SSCs differ from adult SSCs in their ability to engraft, proliferate, and regenerate spermatogenesis in recipient testes after transplantation, using a serial transplantation technique in mice. Testis cells derived from 7-day-old pups were initially injected into control and experimental groups of adult recipient testes. At different times after initial transplantation, recipient testes of experimental group were harvested and the cells recovered from these testes were injected into secondary recipients. Two months after transplantation, colony numbers in recipient testes were compared between the two groups, and recolonization rate was calculated by dividing colony numbers in secondary recipients (experimental) by those in primary recipients (control). When retransplantation was done at 1, 3, 7, and 14 days after initial transplantation, recolonization rate gradually decreased and was the lowest at Day 7 (11.7%) while it rose to ∼22% at Day 14. Thus, ∼12% of pup SSCs injected are estimated to engraft into recipient testes and initiate proliferation by 14 days after transplantation. This homing kinetics was similar to that of adult SSCs, implying that 1-week-old and adult SSCs have a similar homing ability. We then retransplanted pup SSCs at 1 and 2 months after initial transplantation to evaluate their proliferation kinetics following transplantation. The results showed that pup SSCs continuously proliferated ∼9-fold from 1 week to 2 months. During this period, however, the proliferation of pup SSCs was slower than that of adult SSCs. It is thus suggested that SSCs may alter their self-renewal/differentiation kinetics during postnatal development. Supported by CIHR MOP-49444.



          Minisymposium V. Metabolic Interactions: Reproductive Signals from Nontraditional Sources
          Chair(s): MacLaren, Leslie1, 1 Nova Scotia Ag College, Truro, NS, Canada
          Location: CCQ 202

          MS13. EFFECTS OF OMEGA-3 AND -6 FATTY ACIDS ON REPRODUCTION IN DAIRY CATTLE. Thatcher, William1, Bilby, Todd1, MacLaren, Leslie2, Staples, Charles1, Santos, Jose3, 1 University of Florida, Gainesville, FL2 Department of Plant and Animal Sciences, Truro, Nova Scotia, Canada3 University of California, Davis, CA
               Essential fatty acids (FA) are key nutrients to sustain reproductive performance. Increasing delivery of selective FA such as omega () -3 (e.g., -linolenic [C18:3], eicosapentaenoic [EPA; C20:5] and docosahexaenoic [DHA; C22:6] acids) and -6 (linoleic, C18:2) FA for absorption by ruminants is a challenge because of their extensive biohydrogenation by ruminal bacteria. Feeding Ca salts of FA allows for a greater escape of parent unsaturated FA available for absorption and uptake by tissues. EPA and DHA are increased in the endometrium and liver of cows fed Ca salts of fish oil. The -3 EPA inhibited syntheses of PGF2 , PGE2 and PGI2 in immortalized bovine endometrial cells stimulated with phorbol ester. Inhibition of the PG-2 series is due to a competition between EPA and arachidonic acid as substrates for PGHS-2. Feeding either fish meal or fish oil, containing EPA and DHA, reduced oxytocin-induced uterine PGF2 synthesis in the cycle and postpartum (PP) PGF2 synthesis by the uterus. Peroxisome proliferator-activated receptors (PPARs) are a family of orphan nuclear receptors activated by specific FA, eicosanoids, and peroxisome proliferators that may partially mediate uterine responses induced by FA and bovine somatotropin (bST). The PPAR/ subtype is localized in the endometrial luminal and glandular epithelium of the cow at d 17. Endometrial PPAR mRNA is altered by stage of the cycle between d 3 and d 7. Ca salts of fish oil, enriched in EPA and DHA, stimulated steady state concentrations of IGF-II mRNA and progesterone receptor (PR) mRNA in endometrial tissue at d 17 of the cycle. When diets enriched in Ca salts of linoleic acid were fed beginning at d 28 before parturition, early PP secretion of PGF2 from the involuting uterus was increased. Such cows had improved immune competence based on a reduced incidence of PP health problems (e.g., metritis). Studies with Ca salts of both linoleic and monoenoic trans FA fed during late gestation and early lactation improved conception rates in dairy cows by increasing fertilization rate and embryo quality. Further studies are needed to optimize the use of dietary FA as nutraceutical regulators of reproductive performance. Supported by NRI/USDA Grant 2004-35203-14137 (JEPS and WWT).


          MS14. REPRODUCTIVE FUNCTION AND ENERGY BALANCE: LACTATION AS A MODEL. Smith, M Susan1, Grove, Kevin1, 1 Oregon National Primate Research Center/Oregon Health & Science University, Beaverton, OR
               Lactation is a physiological state characterized by a suppression of cyclic reproductive function and negative energy balance, due to the energy drain of milk production. In the lactating rat, the energy drain is met by a 3- to 4-fold increase in food and water intake. Thus, during lactation, an extreme state of hyperphagia, resembling models of obesity, exists concomitantly with a state of negative energy balance, similar to models of fasting. Changes in key arcuate nucleus neuropeptide systems, such as NPY and AGRP (increased), and POMC (decreased), are consistent with the sustained hyperphagia. The suppression of GnRH neuronal activity is likely due to suckling-induced alterations in hypothalamic neural systems that regulate food intake/energy balance. Our studies have established that the orexigenic systems, NPY, orexin, and melanin concentrating hormone, make direct connections with GnRH neurons; thus, they provide a neuroanatomical framework by which signals denoting changes in food intake/energy balance are transmitted directly to GnRH neurons. The arcuate nucleus NPY system appears to play a central integrating role by directly transmitting the effects of suppressed levels of leptin and insulin (peripheral signals reflecting negative energy balance), by providing direct input to GnRH neurons, and by providing indirect input to GnRH through connections to MCH and orexin neurons in the lateral hypothalamic area. Using a microarray analysis of the arcuate nucleus, several genes of interest have been identified as being differentially regulated during lactation: neurokinin B (decreased), IGFBP3 (increased), Gpr 88 (increased) and lactate transporter (MCT1, decreased). These genes are involved in the changes in ARH function arising from the suckling stimulus or the suppressed levels of leptin and insulin. In addition, novel neuropeptide systems in the dorsomedial hypothalamic nucleus, such as the suckling-specific induction of NPY, may be involved in the suppression of GnRH activity and the hyperphagia. An understanding of the changes in hypothalamic function during lactation are yielding new information about the regulation of the reproductive neuroendocrine axis under conditions of negative energy balance, as well as conditions of greatly increased food intake that can lead to obesity.


          MS15. LEPTIN: A HUMAN PLACENTAL HORMONE WITH PLEIOTROPIC EFFECTS. Bischof, Paul1, 1 University of Geneva, Geneva, Switzerland
                It was postulated almost thirty years ago that a certain threshold of body size is necessary before the reproductive system becomes active. The studies of Kennedy and Mitra (1963), established that the timing of puberty is associated with body weight and composition rather than with chronological age. In adults as well, states of under nutrition can lead to suppression of gonadotropins and infertility. These effects seem to result primarily from a decrease in hypothalamic GnRH secretion. The recent cloning of the so-called obesity gene (ob gene) in 1994 by Zhang and colleagues and the characterization of the effects of its product, the leptin protein has brought a new light to this field. Leptin is a secretory product of the adipocyte and circulating letpin levels in the human were shown to correlate significantly with the body mass index (BMI). It has been suggested that leptin acts as an afferent satiety signal to the brain, at least partially by modulating expression of the orexigenic hypothalamic peptide neuropeptide Y (NPY). In the human however, and unlike the ob/ob mouse, obesity is not generally caused by leptin mutations even though such a mutation was recently described. Recently, it was demonstrated that circulating leptin levels were elevated during pregnancy, reaching a peak during the second trimester. However, fat deposition during pregnancy or pregnancy-induced endocrine changes could hardly explain such dramatic changes implying that the feto-placental unit could be another important source of leptin. We observed that leptin is produced by human first trimester cytotrophoblalstic cells (CTB) when cultured in vitro and that oestradiol or interleukin-1 or 6 stimulate its secretion. In-vitro, placental leptin regulates the pulsatile secretion of hCG through a GnRH dependent mechanism and regulates the secretion of the angiogenic factor VEGF (vascular endothelial growth factor). Furthermore, leptin stimulates the release of cytotrophoblastic metalloproteinases stimulating thus the invasive behaviour of trophoblast in early pregnancy. Clearly, leptin has to be considered as a new placental hormone with potent endocrine and metabolic functions.



        Minisymposia VI-X
        Tuesday, July 26, 2005
        9:15 AM–10:45 AM

          Minisymposium VI. Breast Cancer and Biology and Physiology of the Breast
          Chair(s): Conley, Alan1, 1 University of California-Davis, Davis, CA
          Location: CCQ 204AB

          MS16. COX 2, NUCLEAR RECEPTORS AND AROMATASE REGULATION IN BREAST CANCER. Clyne, Colin1, Kovacic, Agnes1, Zhou, Jiong1, Houssami, Souheir1, Sierens, Jayne1, Pathirage, Niroshani1, Simpson, Evan1, 1 Prince Henry's Institue of Medical Research, Melbourne, VIC, Australia
                Aromatase activity in breast tissue is the major source of estrogen driving growth of breast tumors in post-menopausal women. In healthy breast, aromatase is expressed at relatively low level, and expression is controlled mainly by a distal promoter, promoter I.4, in response to locally-produced cytokines and systemic glucocorticoids. In the presence of a tumor, however, local aromatase expression is increased several-fold due to activation of an alternative promoter, promoter II. This is due in large part to stimulation of promoter II by tumor-derived prostaglandin E2, in part explaining the protective effects of COX-2 inhibitors on breast cancer development. Aromatase inhibitors are proving superior to Tamoxifen as endocrine therapy in breast cancer treatment, but these often have a negative impact on bone mineralization, athralgia, as well as cognitive function and hepatic steatosis. The realization of the importance of local aromatase expression together with the use of these different promoters to regulate tissue-specific aromatase expression leads to the concept of selective aromatase modulators (SAMs) that would inhibit aromatase expression exclusively in breast whilst sparing other sites where estrogen synthesis is desirable. One candidate for drug discovery in this context is the orphan nuclear receptor LRH-1, since LRH-1 is critical for aromatase expression in breast but not in other tissues. We are currently exploring potential mechanisms by which LRH-1 activity might be inhibited.


          MS17. EPIGENETIC REGULATION OF ESTROGEN SIGNALING IN BREAST CANCER. Huang, Tim1, 1 The Ohio State University, Columbus, OH
               Extensive genetic and biochemical studies have been undertaken to understand complex mechanisms of estrogen receptor alpha (ER)-mediated signaling. An emerging theme, not yet intensively investigated in this field, is the epigenetic influence on this signaling network. Epigenetics can be defined as the study of heritable changes that modulate chromatin organization without altering the corresponding DNA sequence. Early studies have shown that hypermethylation of the ER promoter is associated with the silencing of its transcript in receptor-negative breast cancer cells. We have investigated the downstream event of ER-mediated signaling. This study has led to the discovery that disruption of ER signaling via RNA interference could trigger a sequence of molecular event that results in epigenetic silencing of its downstream targets. Upon the removal of ER signaling, down-regulation of target genes (e.g., progesterone receptor) occurs immediately within 36 hours. Transcriptional repressors (e.g., polycomb proteins) and histone deacetylases are then assembled to ER-related promoters to initiate long-term transcriptional repression. Subsequent recruitment of DNA methyltransferases to the repressor complex methylates CpG sites in the adjacent area. This process may be gradual, with methylation density increasing over time in the targeted area. The buildup of DNA methylation could set up a heritable mark that may eventually replace some of the original repressors to establish a heterochromatin state of long-term silencing. This epigenetic dysregulation could occur in many downstream ER loci, the silencing of which may contribute to further malignant potential in breast cancer cells.


          MS18. HUMAN CHORIONIC GONADOTROPIN (HCG)- AND PREGNANCY-INDUCED DIFFERENTIATION PROTECT THE BREAST FROM CANCER. Russo, Irma 1, Russo, Jose1, 1 Fox Chase Cancer Center, Philadelphia, PA
               The increasing incidence of breast cancer in women receiving hormone replacement therapy and the worldwide prevalence of the disease in nulliparous women indicate that hormonal and reproductive influences play a major role in breast cancer risk. This postulate has been confirmed by studies carried out utilizing female Sprague-Dawley rats treated with the chemical carcinogen 7,12-dimethylbenz(a)anthracene (DMBA). In this model, maximal tumorigenic response is elicited only when the carcinogen is administered to rats when they are young and virgin, during a window of high susceptibility encompassed between the initiation of ovarian function and the first pregnancy. Administration of DMBA after the first pregnancy fails to induce mammary cancer, an effect mimicked in virgin rats by a 21-day treatment with human chorionic gonadotropin (hCG), a homologue of the pituitary luteinizing hormone (LH). Treatment of tumor bearing rats with hCG also inhibits tumor progression. LH and hCG exert multiple effects in the central nervous system (CNS) and in the ovary through binding to their specific G-protein coupled receptors. The hormonal milieu elicited by the hCG treatment of virgin rats, like pregnancy, stimulates the mammary terminal end buds to differentiate into lobules, which exhibit a reduction in cell proliferation, steroid hormone receptor content, and carcinogen binding, and an increased efficiency in removal of carcinogen adducts. Differentiation also activates the expression of differentiation markers, including the synthesis of inhibin, a secreted protein with tumor suppressor activity, and activation of the apoptotic genes TRPM2, ICE, p53, c-myc, WAF-1 /CIP-1, bcl-XS, and p53. Cluster analysis of mammary gland RNAs obtained during and after pregnancy or hCG treatment and that were hybridized to cDNA array membranes containing 5,800 rat genes revealed that four different patterns of gene clustering are expressed at different time points in correlation with specific stages of development of the mammary gland. Knowledge acquired through these studies will solidify and broaden the potential of this model for developing novel strategies for the prevention and treatment of breast cancer based on physiological mechanisms of gene expression regulation. (Work supported by NIH grant RO1 CA094098).



          Minisymposium VII. Mahesh Neuroendocrine Minisymposium: Androgen Actions in the Developing Female Brain
          Chair(s): Levine, Jon1, 1 Northwestern University, Evanston, IL
          Location: CCQ 206B

          MS19. NEUROENDOCRINE CONSEQUENCES OF PRENATAL ANDROGEN EXPOSURE IN RODENTS. Levine, Jon 1, Foecking, Eileen1, Chamberlin, Melissa1, Huang, Wenyu1, 1 Northwestern University, Evanston, IL
               Sex differences in gonadotropin secretory patterns are established during fetal and perinatal development, when testicular androgen secretions appear to render the developing male brain incapable of producing preovulatory gonadotropin surges in adulthood. In the absence of this androgen exposure, the female preoptic area (POA) and hypothalamus acquire the ability to sustain normal, female-typical cyclic gonadotropin secretions as adults. It is thus generally held that the default developmental pathway for neurons controlling the GnRH surge is female, and that early androgen action in the brain represents a defeminization of this pathway, such that acyclic hormone secretions occur in a neuronal system that would otherwise develop into one capable of supporting cyclic gonadotropin secretion. This idea is strongly supported by the observation that female rodents exposed to exogenous androgens in fetal or perinatal development exhibit male-typical, acyclic gonadotropin secretion patterns. The mechanisms by which early androgen exposure may suppress cyclic gonadotropin secretion in adulthood have remained unclear, and have been a major focus of our studies. We provide new evidence that androgens can exert these organizational effects by prenatally activating androgen receptor, and thereby programming permanent refractoriness of POA neurons to estrogen positive feedback effects. The ability of estrogen to induce progesterone receptors, in particular, is one signaling process that appears to be permanently inactivated by exposure to prenatal androgens. Using candidate gene analysis, as well as microarray gene discovery approach, we have begun to identify other genes whose expression in the POA appears to be permanently altered by prenatal androgen exposure. These studies will hopefully allow for a more thorough understanding of the molecular and cellular events that underlie the ability of androgens to program development of sexually differentiated neurosecretory mechanisms. They may also provide insight into the pathophysiological consequences of androgen action in the developing female brain.


          MS20. PRENATAL ANDROGENS AND THEIR EFFECT ON NEUROENDOCRINE FUNCTION IN EWES. Robinson, Jane1, 1 University of Glasgow, Glasgow, UK
               Exposure of the ewe lamb to androgen during a sensitive window in fetal life leads to severe disruption of reproductive neuroendocrine function. Central to this disruption are factors that influence GnRH secretion from neurons located, primarily, in the preoptic area (POA). Androgens do not alter the migration of fetal GnRH neurons (from the olfactory placode), or GnRH mRNA expression during the course of migration. Rather, they appear to act on the developing hypothalamus to alter the connections formed by GnRH cells with afferent neurons. As GnRH neurons themselves do not contain nuclear progesterone (P) or estrogen (E) receptors, a critically important class of GnRH afferents are those transducing information about steroidal status. This is because the GnRH neurons of androgenised ewe respond inappropriately to steroid feedback leading to abnormal gonadotropin secretion. Specifically, GnRH neurons are unable to respond to follicular phase concentrations of E with a preovulatory-like surge of GnRH. Further, both the negative feedback actions of E and P are compromised. Critical to our understanding of how androgens both organised and activate the GnRH neuronal system is identification of specific steroid sensitive neurons that are functionally altered in androgenised ewes. Our initial focus on the oestrogenic regulation of GnRH release revealed that the androgenised ewe has a significantly greater density of E receptor immunoreactive (ER-ir) neurons in the POA than normal ewes. Interestingly, micro-implants of E directly into this loci have been shown to inhibit GnRH release. In contrast, the mediobasal hypothalamus (encompassing the ventromedial (VMN) and arcuate neuclei (ARC), in which E implants can trigger the GnRH surge in normal, but not androgenised ewes) have a lower density of ER-ir cells in the androgenised ewe. We have used fos as a marker of neuronal activation to identify specific populations of cells in the brainstem, VMN and ARC that are differentially activated by E in control vs androgenised ewes. These approaches aid identification of neurons that are important for the steroidal control of GnRH release in normal animals, as well as those that are programmed by androgens to malfunction and cause abnormal reproductive activity in post natal life. Supported by Wellbeing and BBSRC.


          MS21. EFFECTS OF PRE- AND POSTNATAL ANDROGENS ON REPRODUCTIVE NEUROENDOCRINE CIRCUITRY. Moenter, Suzanne1, Pielecka, Justyna1, Quaynor, Samuel1, Sullivan, Shannon, 1 University of Virginia, Charlottesville, VA
               Steroid driven changes in GnRH release during the reproductive cycle are crucial for fertility. The normal feedback milieu is disrupted by excess androgens, as in polycystic ovary syndrome. We used electrophysiology to examine the effect of adult and prenatal steroid milieu on 1) synaptic transmission from GABA neurons to GnRH neurons, and 2) activity of GnRH neurons. Control adult female mice were ovariectomized with estradiol implants (OVX+E); experimental groups received additional implants of progesterone (P) and/or dihydrotestosterone (DHT). Compared to OVX+E controls, P reduced both the frequency of GABAergic postsynaptic currents (PSCs) in GnRH neurons. As activation of GABA-A receptors depolarizes GnRH neurons and can excite these cells to fire action potentials, P is reducing synaptic drive that is potentially stimulatory to these cells. P also reduced the size of PSCs; as the size of the PSC is proportional to the degree of depolarization it elicits, this reduces the likelihood that GABA-induced depolarizations will be large enough to cross the threshold for action potential initiation. P actions on GABA transmission are reflected by a marked decreased GnRH neuron firing activity in P-treated females. Co-treatment with DHT and P returned both GABA drive and GnRH neuron firing activity to OVX+E levels. DHT alone increased GABA drive to GnRH neurons relative to controls, and preliminary data suggest firing activity may also be increased. To test for a role for prenatal androgens (PNA) in programming adult feedback milieu, pregnant females were injected with DHT and their female offspring studied as adults. PNA mice had irregular estrous cycles and elevated testosterone and LH. GABA drive to GnRH neurons is elevated in PNA mice; all effects were reversed by in vivo treatment of the adult offspring with the androgen receptor blocker flutamide, indicating they were androgen-mediated. These data suggest androgen receptor activation in adults interferes with P negative feedback, in part by blocking the reduction of excitatory GABAergic drive to GnRH neurons by P, and also that elevated androgens augment activity of the reproductive neuroendocrine system. Further, androgen receptor activation during development can reversibly reprogram the GABAergic neurocircuitry afferent to GnRH neurons. NIH U54 HD28934



          Minisymposium VIII. Epigenetics and Imprinting
          Chair(s): Resnick, James1, 1 University of Florida, Gainesville, FL
          Location: CCQ 2000A

          MS22. REGULATION OF IMPRINTING AT THE H19/IGF2 LOCUS. Bartolomei, Marisa1, Fedoriw, Andrew 1, Engel, Nora 1, Wan, Le-Ben1, Schultz, Richard 2, 1 University of Pennsylvania School of Medicine, Philadelphia, PA2 University of Pennsylvania, Philadelphia, PA
               The opposite imprinting of H19 and Igf2 is mediated through shared enhancers and a 2 kb differentially methylated domain (DMD). The DMD is hypermethylated on the repressed paternal H19 allele and hypersensitive to nucleases on the active maternal allele and is required for H19 and Igf2 imprinted expression on both chromosomes. It is postulated that the DMD acts as a methylation-sensitive insulator and hypermethylated mediator of H19 repression on the maternal and paternal alleles, respectively. The insulator activity is mediated, at least in part, by CTCF. Mutation of 9 CpG dinucleotides within the CTCF binding sites disrupts repression and hypermethylation of the paternal H19 allele while maintaining CTCF binding. Because methylation is acquired on the paternal allele during spermatogenesis but lost early in development on this mutant allele, we hypothesize that the binding of CTCF in the preimplantation embryo may contribute to methylation loss on the mutant paternal allele and may also protect the expressed allele(s) from methylation after implantation. The protective role of CTCF at the DMD also appears to extend to the time when maternal methylation is established at other imprinted loci. A transgenic RNAi approach that targets CTCF in the growing oocyte shows that transgenic lines with significant CTCF depletion in the growing oocyte exhibit DMD methylation. Interestingly, the methylation is incomplete in the GV-stage oocyte, with the paternal alleles exhibiting extensive hypermethylation and the maternal alleles remaining unmethylated. Together, these experiments indicate that CTCF binding protects the DMD from DNA methylation. These experiments also suggest that the two roles of the DMD, insulation and repression, are antagonistic.


          MS23. DYNAMIC CHROMATIN CHANGES DURING THE FIRST CELL CYCLE. Dean, Wendy 1, Reik, Wolf1, Santos, Fatima1, 1 The Babraham Institute, Cambridge, UK
               On fertilisation, gametes undergo epigenetic reorganisation and re-establish totipotency. We have investigated links between chromatin remodelling and asymmetric maintenance of DNA methylation during the first cell cycle in the mouse. Using antibodies against a broad repertoire of methylated lysine residues on H3 in the core nucleosome reveals that the male and female pronuclei are organised into chromatin that is modified in very different ways. As an example, the male pronucleus is negative for di- and trimethyl H3K9, modifications associated to inactive euchromatin and heterochromatin respectively, yet the female is positive for these residues. Despite these differences, both pronuclei are transcriptionally inactive at this stage. However, the male is positive for monomethyl H3K9 and H3K27 and these signals increase during pronuclear maturation. Non-histone chromatin proteins of the Polycomb group, Eed and the histone methyl transferase (HMT) activity Ezh2, are also found in the paternal compartment as early as sperm decondensation. However, despite the presence of the HMT usually responsible for trimethyl of H3K27, this residue is not trimethylated in the male pronucleus until the completion of DNA replication. Additional significant chromatin proteins such as Heterochromatin protein 1 beta (HP1) is abundant in the male pronucleus, despite the absence of di- and trimethyl H3K9 the preferred binding partners, but instead HP1 apparently co-localises with monomethyl H3K9. Recent evidence identifies monomethyl H3K9 as the preferred substrate of Suvar39h, the histone methyl transferase (HMT) responsible for heterochromatic H3K9 trimethylation. This association of monomethyl H3K9 and HP1 may assist in preventing further modification of H3K9. Association of dimethylation but not trimethylation of H3K9 with DNA methylation, in the female pronucleus, suggests a mechanistically significant link. These differences begin to provide a chromatin based explanation for paternal-specific active DNA demethylation and maternal specific protection in the mouse.


          MS24. SETTING AND PERTURBING GAMETIC IMPRINTS. Trasler, Jacquetta1, Toppings, Marc1, Reinhart, Bonnie2, Lucifero, Diana1, La Salle, Sophie1, Chaillet, Richard2, 1 McGill University-Montreal Childrens Hospital Research Institute, Montreal, QC, Canada2 University of Pittsburgh, Pittsburgh, PA
               Genomic imprinting involves the formation of an epigenetic mark on a subset of mammalian genes in a parent-of-origin-specific manner, such that the genes affected are expressed monoallelically in the resulting offspring. The process is initiated in the germline and persists through preimplantation development. DNA methylation, catalyzed by the DNA methyltransferase (Dnmt) enzymes,is one of the best characterized epigenetic modifications of imprinted genes. Examination of the methylation status of Snrpn, Igf2r, Peg1 and Peg3 during oocyte development identified the postnatal growth phase as the critical period when maternal methylation takes place. Dnmt3a and Dnmt3l have been shown to be important for the acquisition of maternal methylation imprints whereas Dnmt1o plays a role in the maintenance of gamete-derived imprints in the preimplantation embryo. Expression studies and gene-targeting have been used to examine the regulation and functions of the Dnmts. Real-time RT-PCR showed that Dnmt3a, Dnmt3b and Dnmt3l levels increase 47-, 16-, and 9600-fold during oocyte growth; in Dnmt1o-deficient oocytes, Dnmt3l levels were unchanged, whereas both Dnmt3a and Dnmt3b were upregulated. The consequences of perturbing the maintenance of methylation imprints was examined in 7.5 dpc embryos derived from Dnmt1o-deficient oocytes. Embryos that develop in the absence of Dnmt1o demonstrate striking phenotypic variation between embryos as well as evidence of developmental abnormalities. Loss of methylation at imprinted genes was similar in extraembryonic tissue and different regions of the embryos. Studies are underway to better understand the variable phenotypes and nature of the epigenetic mosaicism in the Dnmt1o-deficient embryos. Supported by NIH, CIHR, FRSQ



          Minisymposium IX. Molecular Mechanisms of Sperm Function
          Chair(s): Bailey, Janice1, 1 Laval University, Sainte Foy, QC, Canada
          Location: CCQ 205ABC

          MS25. SPERM DNA DEGRADATION INTO LOOP-SIZED FRAGMENTS AND ITS POSSIBLE FUNCTIONS. Ward, W. Steven1, 1 Institute for Biogenesis Research, Honolulu, HI
               Several reports from our laboratory and from others have provided evidence that sperm DNA is organized into loop domains attached at their bases to a proteinaceous structure termed the nuclear matrix. Mammalian sperm loop domains have an average size of about 50 kb. This chromatin is also unique in that the histones are replaced almost entirely by protamines. The latter condense the DNA into toroids of about the same size as a loop domain. We have recently proposed the Donut-Loop model for sperm chromatin structure in which one protamine toroid is also one DNA loop domain. According to this model, the protamine toroids are connected by chromatin segments called toroid linkers that are more susceptible to exogenous DNAse I. The protamine linkers also contain the matrix attachment regions (MARs), which are sequences by which DNA is bound to the nuclear matrix. Recent work from our laboratory has demonstrated that mouse, human, and hamster spermatozoa contain nucleases that can cleave the DNA into loop sized fragments. These nucleases require both magnesium and calcium for full effect, and appear to cleave the sperm DNA at the bases of their loop domains, at or near the sites of attachment to the sperm nuclear matrix. Similar nucleolytic events are seen in somatic cells during apoptosis, and have been shown to be caused by topoisomerase II and calcium dependent nucleases. More recently, we have demonstrated that salt extracted sperm nuclei still digest their DNA into loop-sized fragments. This suggests that the nucleases(s) remain associated with the sperm nuclear matrix, and that its primary site of activity is at or near the MAR. Current work in our laboratory is focusing on the possible identity of these nucleases, and whether topoisomerase II is working in concert with other nucleases.


          MS26. HYPERACTIVATION OF SPERM: SWIMMING IN CIRCLES WINS THE RACE. Suarez, Susan1, 1 Cornell University, Ithaca, NY
               In the oviduct, sperm become hyperactivated as they leave the storage reservoir and approach the oocyte. This entails a significant increase in flagellar beat amplitude, usually in the principal bend but not the reverse bend. As a result, hyperactivated sperm swim rapidly in small circles in medium on microscope slides. In the oviduct, however, hyperactivation enhances sperm penetration of viscoelastic substances, such as oviductal mucous secretions and the cumulus matrix. Furthermore, it enables sperm to penetrate the zona pellucida. Because hyperactivation involves a switch to asymmetrical flagellar beating, it has also been implicated in chemotaxis towards the oocyte. Sperm from mouse null mutants for CatSper genes swim actively, but do not hyperactivate. These sperm cannot fertilize in vitro unless the zona pellucida is removed from the oocyte. There is also evidence that CatSper-null sperm can enter the oviduct but cannot ascend it. Thus, despite the observation that hyperactivated sperm swim in circles on microscope slides, in the oviduct sperm must hyperactivate in order to reach the oocyte and fertilize it. Hyperactivation is considered to be a part of the capacitation process, because it occurs under in vitro capacitating conditions in some species. However, hyperactivation can be stimulated independently from acrosomal responsiveness. Hyperactivation is initiated and maintained by an increase in flagellar cytoplasmic calcium. There is evidence that a portion of the redundant nuclear envelope at the base of the flagellum serves as an intracellular calcium store that releases calcium to initiate hyperactivation. In addition, plasma membrane channels, particularly those encoded by CatSper genes, provide calcium to sustain hyperactivation. Little is known of the signaling pathway activated by calcium; however, calmodulin and CaM kinase II have been implicated. Flagellar proteins are phosphorylated during capacitation in vitro; however, their role in the signaling pathway of hyperactivation remains a mystery. NSF MCB-0421855.


          MS27. SPERM CALCIUM DYNAMICS DURING FERTILIZATION. Sutton, Keith1, Jungnickel, Melissa1, Florman, Harvey1, 1 University of Massachusetts Medical School, Worcester, MA
               Fertilization requires the appropriate timing of acrosomal exocytosis in a subset of the spermatozoa that reach the site of fertilization. This calcium dependent exocytotic event allows penetration of the zona pellucida and fusion of the gametes. The temporal and special pattern of calcium signaling in mammalian sperm following stimulation with diverse acrosome reaction inducing agonists has been resolved at ever finer resolution in recent years. Several classes of calcium channel have been implicated in these processes. The calcium signaling events following stimulation with zonae can be crudely divided into early (calcium influx via voltage gated channels), intermediate (calcium release from the internal store following IP3 production) and late (calcium influx via store operated calcium channels). It is this final late phase of calcium influx that drives the elevation of intracellular calcium that is required for fusion of the plasma and acrosomal membranes and thus acrosomal exocytosis. The early events are dependent upon activation of a membrane depolarization signal and the co-activation of g-protein signaling; two events that are required for the triggering of the intermediate and late events. Members of the TRPC family of channels represent strong candidates for the mediators of the sustained calcium influx of the late response and our identification of an adaptor protein that may recruit components of the phosphoinositide signaling pathway to the channel complex suggest a possible point of integration of calcium and kinase signaling during the acrosome reaction.



          Minisymposium X. Endogenous Retroviruses and Reproduction
          Chair(s): Bazer, Fuller1, 1 Texas A&M University, College Station, TX
          Location: CCQ 202

          MS28. ENDOGENOUS RETROVIRUS EXPRESSION DRIVES VILLOUS CYTOTROPHOBLAST DIFFERENTIATION. Rote, Neal1, 2, 1 University Hospitals, Cleveland, OH2 Case School of Medicine, Cleveland, OH
               A major portion of the human genome appears to be of retroviral origin. These endogenous retroviral elements are expressed in a variety of normal tissues, particularly the placenta. Potential roles in normal differentiation of human villous cytotrophoblast into syncytiotrophoblast have been described for at least two endogenous retroviral envelope proteins (HERV-W, ERV-3). A single open reading frame for ERV-3 env is found on chromosome 7. The proposed amino acid structure of ERV-3 Env is highly unusual when compared to similar proteins from infectious retroviruses; lacking a leader sequence, a membrane-spanning domain, and a fusion peptide. Functional studies confirm that ERV-3 Env possesses properties not previously described for retroviral envelope proteins. In villous cytotrophoblast and in the trophoblast model BeWo, ERV-3 mRNA is up-regulated coincident with differentiation measured by loss of proliferative capacity and -hCG mRNA and protein production. Stable transfection of ERV-3 env into undifferentiated BeWo resulted in production of -hCG mRNA and hCG protein, whereas ERV-3 env in the antisense orientation decreased the level of hCG protein expression in differentiating BeWo cells by up to 50-fold. Over-expression also resulted in a 2-fold increase in cAMP, and the effect on b-hCG mRNA and hCG protein expression was specifically prevented by H-89, an inhibitor of protein kinase A. Expression of ERV-3 env decreased proliferative capacity characterized by loss of detectable cyclin B and induction of p21, a condition correlated with cell cycle arrest. Transfection did not greatly increase intercellular fusion, although the transfected BeWo cells retained the capacity to fuse after the addition of forskolin. Combined with other observations on the role of HERV-W in intertrophoblast fusion, it appears that expression of ERV-3 and HERV-W initiates the primary components of villous cytotrophoblast differentiation and successful placentation.


          MS29. FUNCTIONAL PRESERVATION OF THE SYNCYTIN ENCODING RETROVIRAL LOCUS ERVWE1: FROM VIRAL TO CELLULAR FUNCTION. Mallet, Francois1, 1 CNRS-bioMerieux, Lyon, France
               The infectious retrovirus founding the contemporary HERV-W family (Blond et al., 1999) entered the genome of a catarrhine ancestor 25-40 million years ago (Kim, 1999; Voisset et al. 2000). The spread of the HERV-W family into the genome essentially results from autonomous (W-reverse transcriptase) and non-autonomous (LINE-reverse transcriptase) events of intracellular retrotransposition of transcriptionally active copies (Costas 2002; Pavlicek et al. 2002). The HERV-W family contains a unique locus, termed ERVWE1, which encodes an envelope glycoprotein expressed in the placenta (Blond et al, 2000, Voisset et al. 2000). This envelope, also dubbed Syncytin, exhibits fusogenic properties in vitro upon interaction with the type D mammalian retrovirus receptor (hATBo) and is directly involved in trophoblast differentiation (Blond et al. 2000; Mi et al. 2000; Frendo et al. 2003). The functional conservation of the ERVWE1 locus among human and during hominoid evolution (Mallet et al. 2004) and the identification of selective constraints on env gene (Bonnaud et al, 2004) strongly suggest that this retroviral locus has been recruited to play a role in placental physiology. Furthermore, this proviral locus evolved toward a bona fide cellular gene at both transcriptional and protein maturation levels. First, the placental Syncytin expression is regulated by a bipartite element consisting of the retroviral LTR promoter adjacent to a cellular trophoblast-specific enhancer (Prudhomme et al, 2004). Second, the cleavage requirements of the glycoprotein intracytoplasmic tail, crucial for the envelope fusogenic activity, seem to have diverged from classical retroviral maturation (Bonnaud et al, 2004; Cheynet et al, 2005).


          MS30. ENDOGENOUS BETARETROVIRUSES OF SHEEP: BIOLOGICAL ROLES IN UTERINE FUNCTION AND PLACENTAL MORPHOGENESIS. Spencer, Thomas1, Dunlap, Kathrin1, Palmarini, Massimo2, 1 Texas A&M University, College Station, TX2 University of Glasgow, Glasgow, Scotland
               The ovine genome contains approximately 20 copies of endogenous betaretroviruses (enJSRVs) that are highly related to two exogenous oncogenic viruses, Jaagsiekte sheep retrovirus (JSRV) and the Enzootic nasal tumor virus (ENTV), which are the causative agents of naturally occurring carcinomas of the respiratory tract of sheep. The cellular receptor for JSRV and enJSRVs envelope (Env) is hyaluronidase 2 (Hyal2). Recent evidence indicates that enJSRVs interact/interfere at different levels both with the host and with their exogenous and pathogenic counterparts. enJSRVs block replication of the exogenous JSRV by a novel two-step interference mechanism acting both early and late during the virus replication cycle. In adult sheep, enJSRVs are abundantly and specifically expressed in the epithelia lining most of the female reproductive tract. Our working hypothesis is that the enJSRVs in the female reproductive tract protected during evolution the uterus from infection by exogenous and pathogenic betaretroviruses. In addition to the endometrial epithelium, enJSRVs expression is also observed in the conceptus (embryo/fetus and associated extraembryonic membranes). The enJSRVs env is expressed in the conceptus from Day 12, whereas hyal2 was expressed from Day 16. Both enJSRVs env and hyal2 mRNAs are expressed in the placentomes, which are comprised of maternal endometrial caruncles and placental cotyledons. Indeed, the enJSRVs env and hyal2 mRNA is specifically expressed in the trophoblast giant binucleate cells (BNC) and multinucleated syncytial plaques of the cotyledons. Partial sequencing of transcribed enJSRVs from ovine uteroplacental tissues revealed expression of at least 20 different enJSRV loci which contained an open reading frame in env similar to the previously identified enJS5F16 and enJS56A1 proviruses. Delivery of morpholino antisense oligonucleotides, specifically designed to inhibit enJSRVs env translation, into the early pregnant uterus on Day 8 inhibited differentiation of trophoblast BNC on Day 16 as assessed by immunostaining for pregnancy associated glycoproteins. These results strongly support the hypothesis that enJSRVs Env regulates conceptus growth and placental morphogenesis.



        Minisymposia XI-XV
        Wednesday, July 27, 2005
        9:45 AM–11:15 AM

          Minisymposium XI. New Insights Through Modern Approaches into Gamete Biology and Acquisition of Fertilization Competence
          Chair(s): Evans, Janice1, 1 Johns Hopkins, Baltimore, MD
          Location: CCQ 205ABC

          MS31. MAINTENANCE OF MEIOTIC ARREST IN MOUSE OOCYTES BY GPR3 AND Gs. Mehlmann, Lisa1, Saeki, Yoshinaga2, Tanaka, Shigeru2, Brennan, Thomas3, Evsikov, Alexei4, Pendola, Frank4, Knowles, Barbara 4, Eppig, John4, Jaffe, Laurinda1, 1 University of Connecticut Health Center, Farmington, CT2 Ohio State University, Columbus, OH3 Deltagen, Inc, San Carlos, CA4 The Jackson Laboratory, Bar Harbor, MA
               Mammalian oocytes are arrested in prophase I until a surge of luteinizing hormone (LH) causes them to re-enter meiosis and mature into fertilizable eggs. The follicle cells surrounding the oocyte are needed to maintain meiotic arrest prior to the LH surge, although the mechanism by which this occurs is not yet understood. Meiotic arrest is maintained by high levels of cAMP in the oocyte prior to the LH surge, and a Gs G-protein in the oocyte is critical for producing cAMP. We have recently found that the orphan Gs-linked receptor GPR3, which is localized in the oocyte, is also essential for the maintenance of meiotic arrest. Oocytes from Gpr3 knockout mice resume meiosis within antral follicles, independently of an increase in luteinizing hormone, and this phenotype can be reversed by injection of Gpr3 RNA into the oocytes. Thus, the GPR3 receptor is a link in the communication between the follicle cells and oocyte of the ovarian follicle, crucial for the regulation of meiosis. It is possible that the role of the follicle cells in maintaining meiotic arrest is to produce a ligand that stimulates GPR3. We are currently examining the fertility and egg quality of oocytes from Gpr3 knockout mice. In addition, we are testing injection of dsRNA into follicle-enclosed oocytes as an approach for further investigating the role of GPR3 and other signalling molecules that may function in this pathway. Understanding the pathway whereby meiotic arrest is maintained provides a framework for examining the signalling pathway by which LH causes meiotic resumption.


          MS32. INSIGHT INTO SPERM CAPACITATION: TYROSINE PHOSPHORYLATION OF SP32, A PROACROSIN BINDING PROTEIN. Bailey, Janice 1, Dubé, Charlotte1, Leclerc, Pierre 2, Guillemette, Christine1, Beaulieu, Martin1, 1 Université Laval, Quebec City, QC, Canada2 Centre Hospitalier de l'Université Laval, Quebec City, QC, Canada
               Capacitation refers to the collection of cellular modifications that allow mammalian sperm to bind the zona pellucida of the oocyte and undergo the acrosome reaction. Therefore, it is necessary for successful fertilisation in vivo and in vitro, perhaps with the exception of intracytoplasmic sperm injection. Capacitation is a signal transduction-mediated phenomenon, triggered in the absence of a ligand on the sperm, and is regulated by cAMP, calcium, protein tyrosine phosphorylation and as yet unidentified tyrosine kinase(s). We have reported that in porcine sperm, the appearance of a tyrosine phosphorylated protein, p32, coincides with capacitation. Western blotting of pig sperm proteins separated successively under non-reducing then reducing conditions showed p32 only when sperm were incubated in capacitating conditions. Sequencing p32 by MS/MS revealed it to be sp32, a protein involved in acrosin maturation in pig sperm and binds the Mr 55,000 and 53,000 forms of proacrosin as well as the Mr 49,000 acrosin intermediate (Baba et al J Biol Chem 1994 269:10133-40). Our hypothesis, therefore, is that p32 is a tyrosine phosphorylated form of sp32, the acrosomal protein implicated in acrosin activation. Hybridising the same membranes with anti-sp32 antibody demonstrated that sp32 is present in both non-capacitating and capacitating conditions; anti-sp32 recognised the same spot as p32 in extracts from capacitated sperm. Immunoprecipitation with either anti-phosphotyrosine or anti-sp32 antibody corroborated these results. Including calcium chelators in the media demonstrated that the appearance of sp32 is calcium-dependent, similar to what we have previously established for p32. Indirect immunofluorescence with anti-phosphotyrosine antibody or anti-sp32 antibody show similar labelling of capacitated sperm, supporting the hypothesis that p32 is a tyrosine phosphorylated form of sp32. Both indirect immunofluorescent and electron microscopy showed that sp32 is lost from the sperm following the A23187-induced acrosome reaction. Despite these intriguing data, numerous questions remain regarding the regulation of sp32 tyrosine phosphorylation and its importance to sperm function. This project is funded by NSERC; CD and MB were recipients of FQRNT scholarships.


          MS33. RNAi IN THE OOCYTE: A POWERFUL TOOL TO STUDY GENE FUNCTION IN OOCYTE MATURATION AND FERTILIZATION. Stein, Paula1, 1 University of Pennsylvania, Philadelphia, PA
               RNA interference (RNAi) is a conserved post-transcriptional gene silencing mechanism present in most eukaryotes. We have demonstrated that RNAi operates in mouse oocytes and early embryos. We further extended the applicability of RNAi by developing a transgenic RNAi approach to study gene function during oocyte development. The approach utilizes the oocyte-specific Zp3 promoter to drive the expression of a long hairpin double-stranded RNA (dsRNA) that contains sequence complementary to the gene of interest. We validated this approach by targeting Mos and were able to recapitulate the Mos null phenotype. This transgenic RNAi approach has been extended to study the function of other genes involved in oocyte maturation, fertilization and early embryo development. Although RNAi is observed from yeast to humans, mammalian cells possess another pathway that responds to long dsRNA by inducing interferon and expression and activating two dsRNA-dependent enzymes, namely, dsRNA-dependent protein kinase (PKR) and 2′,5′-oligoadenylate synthetase (OAS). PKR activation results in a general inhibition of protein synthesis, while OAS activates RNase L, leading to nonspecific degradation of mRNAs. This antiviral pathway is known as the interferon response. Mouse oocytes and preimplantation embryos seem to lack this response, as potent and specific inhibition of gene expression triggered by long dsRNA is observed in these cells. In order to ascertain whether mouse oocytes can mount an interferon response, we assessed the global pattern of gene expression by microarray analysis in transgenic mouse oocytes exposed to long dsRNA. This analysis, confirmed by real-time PCR and Western blot, shows that PKR, RNase L, and the catalytically active isoforms of OAS are absent in mouse oocytes, while catalytically inactive OAS isoforms, believed to act as dominant negative, are present in large amounts. Transgenic oocytes expressing Mos dsRNA show the same pattern of expression as wild-type oocytes. The microarray analysis also provides invaluable information about the target specificity of RNAi in mouse oocytes and demonstrates the complete absence of off-targeting. We conclude that transgenic RNAi is highly specific in mouse oocytes and therefore is a robust and simple method to study gene function during oocyte development.



          Minisymposium XII. Fertility in the 21st Century: New Approaches to Monitoring and Assessing Human Reproductive Health
          Chair(s): Hunt, Patricia1, 1 Washington State University, Pullman, WA, USA
          Location: CCQ 206B

          MS34. TESTICULAR DYSGENESIS SYNDROME (TDS) AND ENVIRONMENT: A POSSIBLE ROLE OF ENDOCRINE DISRUPTORS. Skakkebaek, Niels E.1, 1 University Department of Growth & Reproduction, Copenhagen, Denmark
               Male infertility has become a major health problem in many Western countries. In Denmark more than 6% of all children are now born after assisted reproduction. Unfortunately the causes are not known in most cases, although spermatogenic failure can be due to Y microdeletions and other rare genetic causes. In addition, testicular cancer, which is a disease of young adults, is becoming more common in industrialized countries. We propose that male infertility, undescended testis, hypospadias and testicular cancer may all be symptoms of one underlying entity, the testicular dysgenesis syndrome (TDS). The most severe form of the syndrome is gonadal dysgenesis in intersex patients and the less severe phenotype may present itself as subfertility due to decreased sperm count. We assume that not only genetic abnormalities cause maldevelopment of the male gonad, but also environmental factors may contribute to an increasing occurrence of TDS. In fact, it has been repeatedly shown that TDS-like symptoms can be produced in rats exposed to phthalates in utero. Our preliminary data from an ongoing study suggests that phthalate exposure via breast milk may lead to decreased Leydig cell function in newborn boys. However, current research raises more questions than answers: Is there a biologically significant chemical exposure of the unborn child through placenta and breast milk. May it affect reproductive function during puberty and adult life? Are we, in the industrialized world, currently witnessing a process, where human fecundity is declining due to adverse environmental exposures?


          MS35. WHAT CAN WE LEARN FROM THE TRANSCRIPTOME PROFILING? - PROMISES AND CAVEATS. Shioda, Toshi1, Coser, Kathryn1, Chesnes, Jessica1, Dean, Kathleen1, Hur, Jingyung1, Isselbacher, Kurt1, 1 Massachusetts General Hospital Center for Cancer Research, Charlestown, MA
               Recent advancements in the DNA microarray technology have provided a wide variety of biomedical research fields with reliable methods to evaluate the transcriptome profile: the quantitative measurement of expression of the mRNA transcripts for all protein-coding genes found in the genome. This technology has been becoming more accessible and affordable in the past couple of years, and it is now considered as one of the key approaches that are to be applied to many biological questions. Attempts to apply the transcriptome profiling to monitor human diseases are about migrating from the proof-of-concept stage to practical applications. The DNA microarray data offer a unique opportunity to perform the unsupervised data analysis, which reasonably classifies the samples and/or the genes without using other information; this approach often provides unexpected, important insights into the physiological and pathological processes. The more classical, supervised data analysis, which finds marker genes for given conditions, is also a powerful approach to obtain the initial insights into the genomic basis of the biological phenomena. However, even when performed by skilled hands, DNA microarray tends to generate large numbers of false positive results, and sometimes such experimentally false positives, which do not relate to the biological phenomena in question, are generated somewhat reproducibly. When DNA microarray is applied to pharmacogenomics and toxicogenomics, in which changes in the transcriptome profile heavily depend on the dose and exposure time of the biologically active chemical compounds, the risk of the false positives increases unless specifically addressed. I will discuss the powerful aspects of the DNA microarray-based transcriptome profiling in pharmaco- and toxicogenomics research and suggest possible applications to the monitoring and assessing human reproductive health. I will also discuss typical pitfalls of this technology.


          MS36. FUTURE FAMILIES: BACKGROUND CONTAMINATION AND HUMAN REPRODUCTIVE HEALTH. Swan, Shanna1, 1 University of Rochester, Rochester, NY
               The Study for Future Families is a multi-center pregnancy cohort study designed to examine geographic variation in reproductive parameters in fertile couples and their offspring. Study participants provided a variety of biological samples including pre- and postnatal urine and serum (from mothers); serum, urine and semen samples (fathers) and urines in early infancy (babies). To date we have measured monoester metabolites of current-use pesticides in urine from a sample of fathers and monoester metabolites of phthalates in urine samples from mothers (pre and post-natal) and infants. In the most agricultural of our study centers centers (Columbia, MO), metabolite levels were significantly associated with poor semen quality for the herbicides alachlor and atrazine, and for the insecticide diazinon (2-isopropoxy-4-methyl-pyrimidinol, or IMPY) (P-values = 0.0007, 0.012, and 0.0004, for alachlor, atrazine and IMPY, respectively). In addition, urinary concentrations of four phthalate metabolites [monoethyl phthalate (MEP), mono-n-butyl phthalate (MBP), monobenzyl phthalate (MBzP), and mono-isobutyl phthalate (MiBP)] in prenatal samples were inversely related to anogenital distance (AGD), a sensitive marker of anti-androgen activity [p-values ranged from 0.012 (MEP) to 0.055 (MBzP)]. Three of the monoesters associated with AGD are the same ones shown to shorten AGD in rodent pups exposed prenatally and the magnitude of the decreases in AGD in human and rodents are comparable. The alterative sources of exposure will be compared based on questionnaire data on product use and correlations between pesticide and phthalate metabolites in biological samples. We will discuss the public health impact of these findings in light of data from a national sample (NHANES) showing that the a substantial fraction of the population of the United States is exposed to these xenobiotics at levels we have shown to be significantly associated with adverse reproductive parameters.



          Minisymposium XIII. Regulation of Reproduction by Molecular Clocks
          Chair(s): Lehman, Michael1, 1 University of Cincinnati, Cincinnati, OH, USA
          Location: CCQ 204AB

          MS37. CLOCK GENES IN PERIPHERAL ORGANS: NEURAL AND ENDOCRINE CONTROL. Bittman, Eric1, 1 University of Massachusetts, Amherst, MA
                Although dependent upon the integrity of a central pacemaker in the suprachiasmatic nucleus of the hypothalamus (SCN), endogenous daily (circadian) rhythms are sustained in a wide variety of peripheral organs. Genes critical to the oscillation, including Per1, Per2, and Bmal1, are expressed in adrenal medulla and cortex, thyroid, ovary, and testis. Rhythmic per2 and bmal1 expression in testis and adrenal is SCN-dependent. Both endocrine and neural signals may function to insure not only the persistence but also the appropriate phasing of peripheral oscillations. We used parabiosis between intact and SCN-lesioned mice to show that non-neural (behavioral or blood-borne) signals are adequate to maintain circadian rhythms of clock gene expression in liver and kidney. Estrogen may regulate some circadian outputs. Uterine per1 expression varies with estrous cycle phase in hamsters, suggesting ovarian control. Furthermore, estradiol regulates the amplitude (but not the period) of mouse activity rhythms. Interestingly, this effect is absent in cryptochrome deficient mice. Estrogen's effects on amplitude may require an intact clock, or cryptochromes may participate in estrogen's actions elsewhere. Neural cues are most likely critical for circadian oscillations in some tissues: rhythmicity of per1 and bmal1 expression is not restored in heart, spleen or skeletal muscle of SCN-lesioned mice by parabiosis to intact partners. Furthermore, abundance of per1 and TH mRNA's is asymmetrical in adrenal medullae of Syrian hamsters in which circadian rhythms split upon exposure to constant light, indicating dominance of neural control. Neurotransplantation is proving a useful tool in determining how the central SCN pacemaker regulates peripheral oscillators. SCN grafts can reinstate circadian rhythms of per1 and bmal1 expression in liver and kidney of SCN-lesioned hamsters, but it is not clear that the result fit the predictions of the model of nonparametric entrainment of the periphery by the pacemaker.


          MS38. CLOCK GENES IN CALENDAR CELLS. Lincoln, Gerald1, Johnston, Jonathan2, Hazlerigg, David2, 1 MRC Human Reproductive Sciences Unit, Edinburgh, Scotland2 School of Biological Sciences, Aberdeen, Scotland
               Seasonal mammals use the duration of nocturnal melatonin secretion as an index of photoperiod to synchronise seasonal physiology to the environment. This photoperiodic response depends on specialised cells (called calendar cells) located in the hypothalamus and pituitary gland that decode the 24-h melatonin signal: long signals (12-16h/d) produce a winter physiology and short signals (<10h/d) produce a summer state. We have selected the pars tuberalis (PT) of the stalk region of the pituitary as a model melatonin-target tissue to investigate the role of clock genes in interpreting the melatonin signal to control seasonal prolactin secretion. The PT-specific cells are thyrotrope-like, express notably high densities of melatonin MT1 receptors, and show a dose- and duration-dependent cAMP response to melatonin. A wide spectrum of clock genes (Bmal1, Clock, Per1, Per2, Cry1, Cry2, Rev-erb, CK1) are rhythmically expressed in the PT, with temporal associations consistent with a cell autonomous circadian clock. Cry1 activation occurs at dusk as a response to melatonin onset, and Per1 activation occurs at dawn as a response to melatonin offset, and the Cry/Per interval varies directly with night length. This suggests a decoding mechanism where a change in abundance of CRY/PER protein complexes may dictate the level of transcription of clock-controlled genes, and thus the downstream seasonal physiology. In Soay sheep, clock gene rhythms in the PT persist under constant light (LL), but are readily reset by exogenous melatonin given at any time of day showing the PT as a slave to the melatonin signal. Circadian clock gene profiles in the ovine PT also faithfully track the melatonin signal in sheep rendered photorefractory under constant photoperiod. This demonstrates that the clock gene rhythms in the PT can be dissociated from the downstream seasonal physiology. Overall, we have evidence for two different cellular timers within the PT: 1) a photoperiod timer that uses circadian clock gene expression to decode the melatonin signal, and 2) a circannual timer that governs photorefractoriness and the generation of endogenous long-term cycles independent of the circadian clockwork. The interaction between the two mechanisms allows for precise timekeeping over months and years.


          MS39. NEURAL AND GENETIC CONTROL OF ENDOCRINE TIMING BY THE CIRCADIAN SYSTEM. Kriegsfeld, Lance1, Mei, Dan Feng2, Bentley, George1, Ukena, Kazuyoshi 3, Tsutsui, Kazuyoshi 3, Silver, Rae2, 1 University of California, Berkeley, CA2 Columbia University, New York, NY3 Hiroshima University, Higashi-Hiroshima, Japan
               The temporal coordination of myriad hormones is necessary for the maintenance of homeostasis and optimal physiological functioning. Traditionally, endocrinologists have focused on the role of negative feedback mechanisms and neuroendocrine pulse generators as the primary mechanisms for temporal organization of hormone secretion. Endogenous timing systems are, however, increasingly implicated in the maintenance of temporal order of hormone production and release. In some instances, neurosecretion is controlled by direct synaptic connections from the mammalian circadian pacemaker located in the suprachiasmatic nucleus (SCN). We have probed this mechanism by specifying the neural projections from the SCN to components of the reproductive axis that control the timing of hormonal events necessary for ovulation. In other systems, we found that neuroendocrine cells express 'clock' genes that regulate circadian function at the cellular level; in this way they exert direct transcriptional control over neuroendocrine releasing factors and adjust their timing. We have used transgenic mice to investigate clock gene expression in neuroendocrine cells; examining expression of a degradable form of recombinant jellyfish green fluorescent protein (GFP), driven by the mouse Period 1 (mPer1) gene promoter, led to the discovery that clock genes are expressed in neuroendocrine cell populations. These cells apparently contain the cellular machinery necessary to oscillate independently. Together, these findings reveal novel mechanisms by which the timing of neuroendocrine responses is modulated by genetic, cellular, and neural regulatory mechanisms controlled by the circadian system. These mechanisms likely act in concert to coordinate the precise timing of endocrine events. These relatively unexplored regulatory interactions represent opportunities for further scientific investigation.



          Minisymposium XIV. Meeting the Demands of the Fetus: A Maternal-Fetal Partnership
          Chair(s): Petroff, Margaret1, 1 University of Kansas Medical Center, Kansas City, KS
          Location: CCQ 202

          MS40. THE FIRST TRIMESTER: CREATING A SUITABLE ENVIRONMENT FOR ORGANOGENESIS. Burton, Graham1, Jauniaux, Eric2, 1 University of Cambridge, Cambridge, UK2 Royal Free and University College, London, UK
               Organogenesis encompasses the period of development from establishment of the primitive streak to closure of the palate. In the human this corresponds to weeks 3-8 post-fertilisation (5-10 weeks menstrual age). It is a period of rapid cell division and differentiation, during which the primordia of the main organ systems are laid down, and hence when the embryo is most vulnerable to perturbations. There is considerable experimental evidence in animal models, and circumstantial evidence in the human, that many teratogens mediate their actions through free radicals, either via their direct effect on DNA to cause mutations or through disruption of signalling pathways. It might be anticipated, therefore, that an important aspect of reproduction is to create a safe and stable environment in which organogenesis can take place. Recent high resolution Doppler imaging, coupled with physiological measurements taken in vivo, has led to a radical reappraisal of the status of the maternal arterial circulation to the placenta during this period. It is now realised that invading endovascular trophoblast cells occlude the tips of the spiral arteries until 10-12 weeks menstrual age, and consequently the oxygen concentration within the feto-placental unit is low (<20 mmHg). Instead, the nutritional demands of the embryo appear to be met in part by secretions from the uterine glands, which remain highly active during early pregnancy and deliver carbohydrate-rich secretions into the placental intervillous space. These nutrients are transported into the exocoelomic cavity, from where they may be taken up by the yolk sac and carried to the embryo. Phylogenetically older metabolic pathways involving non-phosphorylated sugars are highly active in the placental and fetal tissues during this period, and may provide a means of maintaining redox potential under the low oxygen conditions. Once organogenesis is complete at 10 weeks menstrual age the maternal arterial circulation to the placenta starts to be established in a periphery to centre fashion. This is associated with a three-fold increase in intraplacental oxygen concentration, and there is accumulating evidence that failure of the tissues to adapt to this rise lays the foundations of complications of pregnancy such as miscarriage and preeclampsia.


          MS41. UTEROPLACENTAL BLOOD FLOW REGULATION AND FETAL GROWTH DURING GESTATION. Magness, Ronald1, 1 University of Wisconsin, Madison, WI
               During normal gestation uterine and placental blood flows increase dramatically for adequate fetal growth. Perfusion at the maternal-fetal interface occurs via vasodilatation and angiogenic processes. Understanding these mechanisms is important because IUGR leads to increased fetal morbidity and long-term developmental origins of adult onset diseases (i.e. the Barker Hypothesis). Expression of eNOS, NO production, and cGMP are elevated in the uterine and placental endothelial cells and inhibition of NO production reduces blood flow in both the maternal and fetal compartments. Several important interacting factors are implicated in regulating NO production and reproductive blood flows in normal pregnancy including the observed elevated angiogenic factors, estrogen and fluid shear stress. Placental angiogenic factors and NO together play vital roles in regulating placental angiogenesis while also contributing to vasodilatation. Fetal placental angiogenic activity, bFGF, VEGF secretion, and NO production are increased during the third trimester of pregnancy in parallel with fetal growth and uterine and placental blood flows. Interactions are also observed because bFGF and VEGF have the capability of increasing uterine and placental endothelial NO production via elevations in eNOS activation and/or eNOS expression. Estrogen is a potent uterine vasodilator and its levels are also elevated in normal gestation. Blockade of estrogen receptors (ERs) using ICI 182,780 lowers gravid UBF the same amount as the fall seen with NO inhibition using L-NAME. Estrogen also increases de novo NO production by uterine artery endothelial cells (UAECs) via an ER and ERK-MAPK mediated mechanism. Increases in UBF elevate laminar/pulsatile shear stress and uterine vascular NO production. Unlike static UAEC cultures, in the presence of basal shear stress, E2 dramatically augments the rise in eNOS protein expression. Estrogen and shear stress also elevate angiogenic factor expression and contribute to uterine and placental neovascularization. In conclusion, regulation of coordinated rises in blood flows at the maternal-fetal interface is modulated by convergent NO associated mechanisms that are important to fetal development and long-term health. NIH grants HL49210, HD33255, HL57653, HD38843.


          MS42. TESTING THE LIMITS OF MATERNAL-FETAL PARTNERSHIP: ADAPTIVE SUCCESS AND FAILURE UNDER CONDITIONS OF CHRONIC HYPOXIA IN HUMAN PREGNANCY. Zamudio, Stacy1, Caniggia, Isabella2, Illsley, Nicholas3, 1 New Jersey Medical School, Newark, NJ2 Samuel Lunenfeld Research Institute, Toronto, ON, Canada3 New Jersey Medical School, Newark, NJ
               Human pregnancy at high altitude (HA) is a natural experimental model to test the limits of flexibility in placental, maternal and fetal cooperation. HA residence reduces fetal growth (100 grams/1000 m elevation), increases the incidence of preeclampsia 2-4 fold, and, in the absence of high quality medical care, increases maternal, fetal and neonatal mortality. We review here how populations with a long evolutionary history at HA have adapted to the stress of lowered oxygen availability and have ameliorated, but not fully overcome the altitude-associated reduction in fetal growth. This involves fetal, maternal and placental changes related to reduced oxygen availability. At the physiological level, women of HA ancestry have increased blood flow and oxygen delivery to the fetus. Fetuses of HA ancestry have increased oxygen uptake that is proportional to their greater growth, regardless of altitude. Placental structural alterations and maternal and fetal vascular and hematological changes yield greater uteroplacental and fetal blood flows, higher oxygen saturation of the fetal blood and ultimately greater oxygen delivery and uptake in fetuses of HA ancestry. While this contributes to preservation of fetal growth at HA (and larger infants at low altitude), the compensation is not complete, and even the newborns of a genetically adapted population are smaller than their sea level counterparts. At the molecular level there is dissociation of some of the expected effects of hypoxia on placental development and function. Elevated placental hypoxia-inducible factor 1 alpha (HIF-1alpha) message and protein expression are directly correlated with maternal and placental factors relevant to pregnancy outcome at HA, including placental capillary density, maternal circulating VEGF and erythropoietin levels. Elevation in HIF-1alpha in the HA placenta likely contributes to increased placental vascularity, but basal syncytial membrane glucose and amino acid transporter densities are reduced. With respect to glucose this contrasts with in vitro studies and suggests that factors either indirectly related to hypoxia or separate from hypoxia contribute to the reduction in fetal growth at HA, despite preservation of oxygen delivery in the pregnancies of well-adapted populations. Support NSF BCS 0309142, NIH HD 42737.



          Minisymposium XV. Transcriptional Regulation of Gene Expression in the Ovary
          Chair(s): Davis, John,
          Location: CCQ 2000A

          MS43. MOLECULAR REGULATION OF FETAL OVARY DEVELOPMENT. Koopman, Peter1, 1 The University of Queensland, Brisbane, QLD, Australia
               We are investigating the early development of the vertebrate ovary – that is, the steps prior to formation of definitive follicles. To this end we have undertaken screens comparing gene expression in mouse fetal ovaries relative to testes, and different stages of ovarian development. We are particularly interested in identifying genes that may encode transcription factors involved in regulating cell type specification, and components of signalling pathways that may be involved in communication between cell types and co-ordination of the histogenesis of the early ovary. We have identified a large number of genes whose expression is upregulated in fetal ovaries shortly after sex determination, and are in the process of analysing the cell type-specificity and timing of expression of these genes which, together with information regarding the class of protein encoded, prioritizes the genes for further study. One gene resulting from these screens encodes the forkhead transcription factor Foxl2. Mutations in human FOXL2 underlie blepharophimosis ptosis epicanthus inversus syndrome (BPES), characterised by facial dysmorphology, combined in some cases with ovarian failure. We detected Foxl2 expression in embryonic ovaries of mice, chickens and red-eared slider turtles around the time of sex determination, associated with both somatic and germ cell populations. Moreover, sequence analysis of turtle and chicken FoxL2 orthologues indicated an unusually high degree of structural conservation during evolution. Our observations, combined with recent knockout analyses, are consistent with BPES resulting from early abnormalities in regulating the development of the foetal ovary, and identify Foxl2 as one of the earliest known regulators of ovarian development. Overall our results point to a surprising degree of transcriptional complexity in the fetal ovary at stages prior to overt histological differentiation.


          MS44. EPIGENETIC REGULATION OF TRANSCRIPTION IN OVARIAN CANCER. Nephew, Kenneth1, 2, Huang, Tim3, Wei, Susan3, Balch, Curtis1, Brown, Robert4, 1 Indiana University School of Medicine, Bloomington, IN2 Indiana University Cancer Center, Indianapolis, IN3 The Ohio State University, Columbus, OH4 Glasgow University, Glasgow, UK, Scotland
               Ovarian cancer is the most lethal gynecological malignancy and fifth leading cause of cancer death worldwide. Aberrant epigenetic regulation, such as CpG island methylation and associated transcriptional silencing of genes, has been implicated in a variety of human diseases, including ovarian cancer. Our group, utilizing a microarray-based technique known as differential methylation hybridization, examined 19 advanced ovarian cancer patients, for 7700 specific loci. Hierarchical clustering revealed the delineation of two groups of patients, corresponding to high vs. low levels of concurrent DNA methylation. Independently, it was found that the high methylation group bore a significant shorter progression-free survival (PFS less than 8 months versus greater than 12 months). Specifically, we identified 182 methylated sequences significantly associated with short PFS; we are now in the process of characterizing those sequences for patterns that could predict DNA methylation. In a separate approach, we are examining the possibility of re-expression of silenced ovarian cancer tumor suppressor genes by inhibition of DNA methylation. To this end, we are investigating a novel inhibitor, zebularine, and comparing its effect to the well-established (but relatively unstable) inhibitor 2-deoxy-5-azacytidine (DAC). In widely utilized ovarian cancer cell lines, we found that zebularine exerted impressive antigrowth effects, greater than those elicited by DAC. Further, zebularine effected impressive demethylation and induction of two tumor suppressor genes, hMLH1 and RASSF1A. To examine global methylation effects, we performed methyl acceptance and differential methylation hybridization analyses. While we found statistically identical demethylation by both zebularine and DAC, we discovered differences in demethylation of specific genes by the two agents. Finally, we found that zebularine could resensitize a platinum-resistant ovarian cancer cell line to cisplatin. As epigenetic dysregulation is responsible for the transcriptional silencing of hundreds of genes in ovarian tumors, epigenetic-based agents, both alone and in combination with conventional agents, may provide effective therapeutic approaches for this devastating disease.


          MS45. FoxO3 AND PRIMORDIAL FOLLICLE ACTIVATION. Castrillon, Diego1, Gallardo, Teresa1, John, George1, 1 University of Texas Southwestern Medical Center, Dallas, TX
               In mammals, oocytes arrested in the diplotene stage of meiosis become invested soon after birth in a single layer of pregranulosa cells to form primordial follicles, the reserve precursor pool for maturing follicles during reproductive life. Primordial follicle activation (PFA) is the metered process by which small numbers of primordial follicles are selected from this reserve pool into the growing follicle pool. This process is irreversible, in that follicles that have initiated growth undergo atresia if not selected for subsequent stages of maturation. PFA is a delicately balanced and tightly regulated process ensuring that some number of growing follicles is available during each estrus/menstrual cycle while preserving the majority of follicles for later in life, thereby forestalling depletion of oocytes and reproductive senescence. Despite advances in our understanding of many aspects of ovarian function, the mechanisms that regulate PFA remain largely obscure. We have shown that the forkhead transcription factor FoxO3, which functions downstream of the PI3K/AKT pathway, is a master regulator (suppressor) of PFA. FoxO3-null females undergo global PFA within a few days of birth, leading secondarily to increased atresia, premature depletion of ovarian follicles, and consequent female infertility. Our model, which we are currently validating by several approaches, is that FoxO3 functions within the oocyte itself to suppress follicle activation via the transcriptional regulation of currently unknown targets. To begin identifying and validating physiologically relevant transcriptional targets of FoxO3, we have compared mRNA profiles of FoxO3-deficient and wild-type control ovaries soon after birth and prior to the onset of follicle activation. Analyses of additional time points during and immediately following the onset of global primordial follicle activation in FoxO3-deficient ovaries has permitted a unique view of ovarian genes that are induced during PFA and early follicle growth.


          MS46. REGULATION OF TRANSFORMING GROWTH FACTOR-BETA1 (TGF) TRANSCRIPTION BY THE EARLY GROWTH RESPONSE FACTOR 1 (Egr1) TRANSCRIPTION FACTOR IN THE CORPUS LUTEUM (CL). Hou, Xiaoying1, 2, Arvisais, Edward1, 2, Davis, John1, 2, 1 University of Nebraska Medical Center, Omaha, NE2 VA Medical Center, Omaha, NE
                In mammals, including primates and humans, prostaglandin F2 (PGF2) is believed to be the trigger that induces the regression of the CL, whereby progesterone synthesis is inhibited, the luteal structure involutes, and the menstrual or estrus cycle resumes. However, the cellular and molecular mechanisms of PGF2-induced CL regression remain poorly understood. As it is well established that PGF2 activates the PKC/Raf/MEK/ERK signaling pathway, our objectives were to identify genes responsive to PGF2 and activators of this pathway. Our data demonstrate that the expression of Egr1 mRNA and protein is up-regulated in the CL during PGF2-induced luteolysis in vivo and in PGF2-treated luteal cells in vitro. Studies have shown that Egr1 protein can induce the activation of various proapoptotic proteins, suggesting that Egr1 may play a role in luteal regression. Our hypothesis is that Egr1 mediates the actions of PGF2 by inducing the expression of key proapoptotic proteins. Egr1 protein was elevated in nuclear extracts prepared from PGF2-treated cells, and nuclear extracts bound a GC-rich Egr1 consensus motif, indicating that the newly synthesized Egr1 transcription factor was functional. Using a variety of chemical and genetic approaches, the PKC/Raf/MEK/ERK pathway was identified as the proximal signaling event required for the induction of Egr1 in PGF2-treated cells. TGF is believed to exert proapoptotic effects in many cell types, and is expressed in the CL during regression. Treatment with PGF2 increased the expression of TGF mRNA and protein in bovine luteal cells. The effect of PGF2 on TGF expression was mimicked by PKC activators or overexpression of Egr1. The stimulatory effect of PGF2 on TGF mRNA and protein secretion was inhibited by blockade of PKC/Raf/MEK/ERK signaling and overexpression of NAB2, a co-repressor that binds to and inhibits Egr-1 transcriptional activity. Treatment of luteal cells with TGF reduced progesterone secretion and DNA synthesis, implicating TGF in luteal regression. These studies demonstrate that PGF2 via the PKC/Raf/MEK/ERK signaling pathway regulates the expression of Egr1 and TGF in the CL. We suggest that Egr1 may play a role the induction of genes that coordinate the regression of the CL.




Online publishing provided by
Allen Press, Inc. | 810 E. 10th St. | Lawrence, Kansas 66044 USA
e-mail abserv@allenpress.com | Web www.allenpress.com
All material is copyright © 2005 SSR